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If you can't fly, run,  
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Abstract 
 
Gram-negative bacteria cell envelope is a complex structure that is 
constantly exposed to its environment. It is composed of an Inner-
membrane (IM), a thin peptidoglycan layer and an Outer-membrane (OM)a. 
The main component of the OM are Lipopolysaccharides (LPS), also 
termed as endotoxins. Those molecules are composed of three main parts: 
a polysaccharide named the O-antigen, a core oligosaccharide and a Lipid 
Ab. Endotoxins lacking the polysaccharide are termed Lipooligosaccharides 
(LOS). 
 
 
 
General structure of LPS and LOS 
 
LPS are known to interact with mammal’s innate immunity through 
the Toll-like receptor 4 (TLR4) and Myeloid Differentiation factor 2 (MD-2) 
receptorial complexc. Depending on their structure, and in particular on their 
                                                          
a Silhavy, T.J.; Kahne, D.; Walker S.; Cold Spring Harb. Perspect. Biol. 2010, 2:a000414 
b Raetz, C.R.H.; Whitfield C.; Annu. Rev. Biochem. 2002, 71, 635–700 
c Kieser, K.J.; Kagan J.C.; Nat. Rev. Immunol. 2017, 17, 377-390 
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Lipid A, LPS can either have an agonist or an antagonist activityd. 
Discovering new LPS structure is hence necessary in order to develop new 
therapies, since agonist LPS can be used as vaccines adjuvant and 
antagonist as drugs against sepsis and septic shock. 
In this context, LPS structures from various bacterial sources are 
currently under study. This project present the characterization of LPS and 
LOS extracted from marine and halophilic bacteria. As those organisms live 
in a particular environment, they developed specific strategies to adapt 
themselves and were hence investigated, as their LPS structure can be 
shaped by the adaptation to their environmente. In particular, the study of 
LPS from the following strains is here reported.  
 
Pseudoalteromonas sp1A1 is a sponge-pathogen bacterium isolated 
from Suberites domunculaf. The full structure of its LPS was resolved using 
NMR spectroscopy and Matrix assisted laser desorption (MALDI) Mass 
spectrometry (MS). Its O-antigen is a branched polysaccharide that have 
two remarkable features: (i) it possesses a pyruvate linked at 4,6-position of 
a Glucosamine and (ii) it possesses a 9-carbon ulosonic acid that is the 3-
deoxy-D-glycero-D-galacto-nonulosonic acid (KDN). 
-Man -Qui3N-(1 3)--GlcN
6--Glc-(1 3)--GlcN4,6pyr-(1 7)-KDN-2
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Structure of the O-antigen from Pseudoalteromonas sp1A1 
                                                          
d Molinaro, A; Holst, O; Di Lorenzo, F; Callaghan, M; Nurisso, A; D’Errico, G; Zamyatina, A; Peri, F; Berisio, R; 
Jerala, R; Jimenez-Barbero, J; Silipo, A; Martin-Santamaria, S.; Chem. Eur. J. 2015, 21, 500 – 519 
e Di Lorenzo, F.; Billod, J.M.; Martín-Santamaría, S.; Silipo, A.; Molinaro, A. Eur. J. Org. Chem. 2017, 28, 4055–
4073 
f Gardères, J.; Bedoux, G.; Koutsouveli, V.; Crequer, S.; Desriac, F.; Le Pennec, G.; Mar. Drugs 2015, 13, 4985-
5006 
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The Lipid A from Pseudoalteromonas sp1A1 was studied by MALDI 
MS. It is constituted of a mixture of tri- to penta-acylated species, among 
the penta-acylated Lipid A species, at m/z 1474.6 and 1446.6 were bis-
phosphorylated species composed respectively of four C12:0 (3-OH) and 
one C12:0 and two C12:0 (3-OH), one C10:0 (3-OH), one C11:0 (3-OH) 
and one C13:0. 
 
Structure Pseudoalteromonas sp1A1 Lipid A species 
 
 The structure of the core oligosaccharide from Pseudoalteromonas 
sp1A1 LPS was also resolved and turned out to be composed of a 
pentasaccharide containing one Kdo, one heptose, two galactoses and one 
glucose.  
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Structure of Pseudoalteromonas sp1A1 LOS 
 
Pseudoalteromonas sp1A1 biological activity was assessed using 
ELISA and Quanti-blue assays. It was found that its LPS does not possess 
any significant immunostimulant activity on human and murine cell line. The 
Outer-Membrane properties of Pseudoalteromonas sp1A1 were also 
studied through Molecular Dynamic (MD) simulation, that showed how the 
asymmetric repartition of Pseudoalteromonas sp1A1 Lipid A influenced the 
properties of the phospholipid bilayer, increasing its flexibility. Finally, MD 
simulation was also performed with Pseudoalteromonas sp1A1 LOS in 
water and in 0.5 M of NaCl, that is closed to the natural marine environment 
of the bacterium. Results showed that the presence of salts influenced the 
conformational behavior of the Kdo-Lipid A region. 
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 The second bacterial strain studied was Spiribacter salinus M19-40T, 
a halophile isolated from an intermediate salinity pound of a marine saltern 
in Spain, the structure of the Lipid A was resolved using MALDI MS and 
MS2 experiment. It is a mono-phosphorylated and penta-acylated species 
bearing two C10:0 (3-OH), one C12:0, one C14:0 (3-OH) and one C14:0 (3-
oxo). This structure possesses two interesting structural features: (i) the 
2+3 symmetry that is unusual - as most penta-acylated Lipid A have a 3+3 
symmetry and (ii) the occurrence of the C14:0 (3-oxo)g.  
 
 
Structure of the Lipid A from Spiribacter salinus M19-40T 
 
Halopeptonella vilamensis is a halophilic bacterium that have been 
isolated from a saline lagoon in Argentinah whose Lipid A was 
characterized using MALDI MS and MS2 experiments. Results showed that 
H. vilamensis has a highly heterogeneous mixture of Lipid A species, 
mono-phosphorylated and hexa-acylated, that differ for the length and 
saturation of their acyl chains. H. vilamensis main Lipid A species 
possesses two C10:0 (3-OH), two C12:0 (3-OH), one C12:0 and one C12:1. 
                                                          
g Barrau, C.; Di Lorenzo, F.; Javier Menes R.; Lanzetta R.; Molinaro A.; Silipo A.; Mar. Drugs 2018, 16, 124 
h Menes, R.J.; · Viera, C.E.; Farías, M.E.; Extremophiles, 2016, 20, 19–25 
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Another major species possesses only saturated C12:0. Immunological 
assays were performed on murine and human cell lines with H. vilamensis 
LOS and demonstrated its slight immunopotency. 
 
 
Structure of the Lipid A from Halopeptonella vilamensis 
 
Finally, the characterization of cell envelope components of 
Halomonas smyrnensis was also attempted. H. smyrnensis is an 
Exopolysaccharide (EPS) producing halophile isolated from a Turkish salt 
lakei. It is known to be a high levan producer and two novel EPS were 
isolated. The first one is formed by α-(1→4)-Glc polymer and the second 
one by α-(1→3)-GlcNAc units.  
  
                                                          
i Poli, A.; Nicolaus, B. ; Denizci, A.A. ; Yavuzturk, B. ; Kazan, D. Int. J Syst. Evol. Microbiol. 2013, 63, 10-18 
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Abbreviation 
 
BMDM Bone marrow-derived macrophage 
COSY Correlation spectroscopy 
CPS Capsular polysaccharide 
CWA Cell-Wall associated protein 
DFQ-COSY Double-quantum filtered COSY 
DOC Sodium Deoxycholate 
ELISA Enzyme-linked immunosorbent assay 
EPS Exopolysaccharide 
Gal Galactose 
GalNA Galactaminuronic acid 
GC-MS Gas chromatography - Mass spectrometry 
Glc Glucose 
GlcA Glucuronic acid 
GlcN Glucosamine 
HEK Human Embryonic Kidney 
HMBC Heteronuclear multiple-bond correlation 
HSQC Heteronuclear single-quantum correlation 
IL Interleukin 
IM Inner membrane 
IMP Inner membrane protein 
KDN 3-deoxy-D-glycero-D-galacto-nonulosonic acid 
KDO 3-deoxy-D-manno-oct-2-ulosonic acid 
LOS Lipooligosaccharide 
LPS Lipopolysaccharide 
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LTA Lipotechoic acid 
MALDI Matrix assisted laser desorption/ionization 
Man Mannose 
MD-2 Myeloid Differentiation factor 2 
MDS Molecular dynamic simulation 
MOMs Monocyte-derived macrophages 
MS Mass spectrometry 
MyD88 Myeloid Differentiation primary response protein 88 
NF-κB Nuclear factor-κB 
NMR Nuclear magnetic resonance 
NOESY Nuclear Overhauser effect spectroscopy 
OM Outer membrane 
OMP Outer membrane protein 
PAGE Polyacrylamide gel electrophoresis 
PAMP Pathogen associated molecular pattern 
POPE Palmitoyloleoyl Phosphatidylethanolamine 
POPG Palmitoyloleoyl Phosphatidylglycerol 
PRR Pattern recognition receptor 
QuiN Quinovosamine 
SDS Sodium dodecyl sulfate 
SEAP Secreted alcaline phophate 
TH T-Helper cell 
TLR4 Toll-like receptor 4 
TNF Tumor necrosis factor 
TOCSY Total correlation spectroscopy 
TOF Time of flight 
WTA Wall techoic acid 
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Chapter 1: Gram-negative bacteria 
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1.1. The bacterial cell 
 
From microorganisms to complex plants and animals, life comprise a 
remarkable diversity and can be divided into a five-kingdom system that 
includes Monera, Protista, Plantae, Fungi, and Animalia (Figure 1). Around 
30 year ago, Woese et al.1 changed the previous system based on RNA 
analysis. They established the three-kingdom system and defined Bacteria 
as one of the three domains of life, with Archaea and Eukarya (Figure 1). 
Eukarya are uni- or pluricellular organisms that possess an internal cell 
compartmentation. Indeed, the presence of organelles within their 
cytoplasm is characteristic of this domain. Archaea are unicellular 
prokaryotic organisms devoid of cellular compartmentation. Bacteria are 
also prokaryotes but they differ from Archaea, inter alia, by the composition 
of their plasmatic membrane. 
 
 
 
 
 
 
 
 
 
 
Figure 1: The five-kingdom and three-kingdom systems of life  
 
Bacteria include a vast group of microorganisms that grow and 
reproduce in diverse environments. They comprise an impressive array of 
Bacteria 
Archae 
Eukarya Monera 
Protista 
Plantae 
Fungi 
Animalia 
Five-kingdom system Three-kingdom system 
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sizes, shapes and arrangement2. Roughly, Bacteria can be divided on the 
basis of their cell morphologies, e.g. rod shape, spherical and curved cells 
are respectively called “bacillus”, “cocci” and “spirilli”3. Despite the great 
diversity, there are still general features among bacteria (Figure 2). Their 
cytoplasm comprises most bacteria metabolites and is the place where all 
transcription and replication of the DNA occurs. Exposed outside the 
bacteria, flagella and pili are involved in motility. They are anchored in the 
bacterial cell envelope, which possesses a sophisticated architecture. 
 
 
 
 
 
 
 
 
Figure 2: Schematic representation of general bacteria composition 
  
1.2. Bacterial cell envelope 
 
 Bacterial cell envelope is a complex structure that evolved to adapt 
to the environment in which they live. Based on their cell external structure, 
two types of bacteria can be distinguished: Gram-positive and Gram-
negative bacteria. Historically, those category were termed based on a 
colorimetric test developed in 1884 by Hans Christian Gram. Nowadays, 
this determination is still used to describe the bacterial cell envelope 
composition4. 
Flagella 
Ribosome 
DNA 
Pili 
Cytoplasm 
Plasma 
membrane 
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Figure 3: Schematic representation of Gram-positive and Gram-negative bacteria cell 
envelope. Abbreviations correspond to: Wall techoic acid (WTA), Lipotechoic acid (LTA), 
Lipopolysaccharide (LPS), Inner membrane protein (IMP), Cell-wall associated protein 
(CWA); Outer membrane protein (OMP) 
 
Gram-positive cell envelope is composed of two main parts: the cell 
membrane and the cell wall (Figure 3). The cell membrane is a 
phospholipid bilayer. As bacteria do not possess any organelle, all 
membrane-related biosynthesis occur in the cell membrane, including the 
synthesis and transport of molecules composing the cell wall5. This bilayer 
also includes inner membrane proteins (IMP). Over this structure, and 
directly exposed to the environment, there is the cell wall that is composed 
of a thick layer of a glycopeptide polymer named peptidoglycans. On this 
structure are exposed different types of cell-wall glycopolymers6: Wall 
techoic acids (WTA) are linked to the peptidoglycan through 
phosphodiester linkages and lipotechoic acids (LTA) are anchored to the 
cytoplasmatic membrane through a glycerol phosphate unit. Cell-wall 
glycopolymer are diverse among bacteria species and strains and possess 
different ionic charges or number of repeating unit. They are essential for 
Gram-positive bacteria survival, playing a role in important functions as 
Gram-positive Gram-negative 
Inner 
membrane 
Outer 
membrane 
Periplasm 
Inner 
membrane 
OMP 
IMP IMP 
CWA 
WTA 
Cell Wall 
LTA 
LPS 
Peptidoglycan 
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protection, attachment and colonisation. There are also cell-wall associated 
proteins (CWA) that are exposed at the surface of the cell wall. 
Differently from Gram-positive bacteria, Gram-negative cell envelope 
do not have its peptidoglycan exposed to the environment. It is composed 
of three parts: the inner membrane, the periplasm and the outer membrane 
(Figure 3). As for Gram-positive bacteria, the inner membrane is a 
phospholipid bilayer that plays a key role for the biosynthesis of Gram-
negative other cell wall constituents7. Between the two membranes, the 
periplasm is composed of a peptidoglycan layer that is thinner than the one 
found in Gram-positive bacteria and in turn surrounded by the outer 
membrane (OM). The OM is a lipid bilayer that acts as a barrier between 
bacteria and their environment. The OM includes outer membrane proteins 
(OMP) that are β sheets anchored to the bilayer through hydrophobic 
residues. Contrary to the inner membrane, the outer membrane is an 
asymmetric bilayer. Its inner leaflet is still made of phospholipids but its 
outer leaflet is composed at 75% of Lipopolysaccharides (LPS). LPS are 
complex molecules that are crucial for the bacteria survival as they are 
constantly interacting with their environment. 
 
1.3. Lipopolysaccharides and Lipooligosaccharides 
 
 1.3.1. General structure 
  Lipopolysaccharides (LPS) are heat-stable amphiphilic molecules. 
Initially referred as endotoxins, they are anchored in the bacterial cell 
membrane and are infamously known for their toxicity. LPS are composed 
of three main parts8: a repeating unit of polysaccharide termed the O-
antigen, the core oligosaccharide, and the Lipid A (Figure 4). Smooth-type 
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LPS (S-LPS), or Lipopolysaccharides (LPS), are composed of all the three 
previously mentioned parts. Rough LPS (R-LPS), or Lipooligosaccharides 
(LOS), do not possess the O-antigen. The Smooth/Rough determination 
was originally adopted because of the appearance R-LPS and S-LPS give 
to their bacteria colonies. 
 
Figure 4: General structure of Lipopolysaccharides (LPS) and Lipooligosaccharide (LOS) 
 
Lipopolysaccharides are essential for the bacterial survival. Indeed, 
they are crucial in many biological roles as adhesion, symbiosis and 
pathogenicity. In particular, their structure determines the relationships 
between bacteria and their host. Although LPS share the same broad 
architecture, each bacterial strain possesses their own variation. Those 
differences can be seen in the composition of the O-antigen, the core 
oligosaccharide and the Lipid A.  
 
1.3.2. The O-antigen 
The O-antigen is the most variable part of the LPS. It is a hydrophilic 
polymer that can be composed up to 50 units of from 1 up to 8 
monosaccharides. O-antigens can be linear or branched polysaccharides, 
structural variation of the O-antigen occur in the nature of each 
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monosaccharide, their linkages and the presence of non-carbohydrate 
constituents. Non-stoichiometric modifications increase the heterogeneity of 
O-antigen structures. Differences between O-antigen can be observed 
between each bacterial strain (inter-strain specific) but also within the same 
bacterial strain (intra-strain specific). For example, E. coli has more than 
170 O-serotypes. A single bacterium can synthetize O-antigen with different 
number of repeating units. The structure of O-antigen play a role in 
bacterial pathogenicity and symbiosis9. Its length also influences the 
adhesion properties of the LPS10. Interestingly, Gram-negative bacteria can 
shorten their O-antigen using a reversible process called phase-variation11, 
allowing them to hide from the host immune defence. 
 
 1.3.3. The Core Oligosaccharide 
 The core Oligosaccharide has less chemical diversity than the O-
antigen and is composed of two main parts: the Inner and the Outer core 
(Figure 4). The Outer Core is directly linked to the O-antigen and has the 
most structural variations. It is often made of negatively charged 
monosaccharides such as uronic acids. The Inner core is a more conserved 
part. It is typically made of 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) and 
L-glycero-D-mannoheptose (L,D-Hep)12 (Figure 5); D-glycero-D-talo-oct-
ulosonic acid (Ko) or D-glycero-D-mannoheptose (D,D-Hep). The Inner core 
is usually decorated with phosphates (P). 
 
Figure 5: Structure of (1) 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) and (2) L-glycero-D-
mannoheptose (L,D-Hep) 
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 1.3.4. The Lipid A 
The lipid A is the hydrophobic part of the LPS that anchors the 
molecule within the OM. It is composed by a phosphorylated and acylated 
β(1’→6) di-Glucosamine backbone (GlcN)13 on which the core 
oligosaccharide is attached at C-6’ position. The Lipid A can possess one 
or two phosphates linked on the C-4’ position of the non-reducing GlcN 
(GlcN II) and on C-1 position of the reducing GlcN (GlcN I). Lipid As mainly 
differ on their degree of acylation and the nature of their fatty acids. They 
are acylated by primary fatty acids on C-2, C-3, C-2’ and C-3’ position 
through ester and amide bounds. They can also possess ester-linked 
secondary fatty acids that are attached on the hydroxyl group of primary-
linked acyl chains. Finally, Lipid As can also possess substituents as 
phosphoethanolamine. The first resolved Lipid A structure was from E. coli. 
It is a bis-phosphorylated and penta-acylated structure with 4+2 symmetry. 
Many other Lipid As from various bacteria sources pathogen (Figure 6) 
were characterized revealing their highly diverse architectures14,15,16,17. The 
Lipid A structure is crucial for the survival of the bacteria and its 
pathogenicity. Indeed, this moiety is known to directly bind with a 
receptorial complex of mammal’s innate immunity composed of Toll-like 
receptor 4 (TLR4) and myeloid differentiation factor 2 (MD-2).  
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Figure 6: Structure of Lipid As from several bacteria, illustrating their structural diversity 
among Gram-negative bacteria. (A) Escherichia coli (B) Helicobacter pyroli (C) 
Porphyromonas gingivalis (D) Salmonella minnesota (E) Rhodobacter sphaeroides 
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1.4. Gram-negative bacteria and innate immunity 
 
 1.4.1. Innate and adaptive immunity 
Living organisms develop ways to defend against threats in order to 
survive. Immunity is a complex system that allows the host to detect and 
supress the intruding pathogens. In 1989, Charles A. Janeway introduced 
the concept of innate and adaptive immunity18. The organism’s ability to 
prevent infections is broadly based on adaptive immunity. This response is 
highly specific and is developed after a first encounter with a pathogen. 
However, around 7 days are needed to recruit the specialised cells during 
the first activation19. Therefore, a first line of defence is needed to protect 
the organisms against new pathogens. This is the role of innate immunity 
 
Figure 7: An overview of the innate and adaptive immunity. PAMP: Pathogen-associated 
Molecular patterns; PRR: Pathogen-Recognition Receptors; TH: T-helper cells  
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Part of the innate immune response is performed by macrophages 
via phagocytosis (Figure 7). However, dendritic cells (DC) play a key role in 
the innate immune recognition and the induction of adaptive immunity20. 
Briefly, their activation leads to the secretion of cytokines or direct cell 
contacts with naïve T cells that triggers the formation of T and B cells 
(Figure 7). The first step in the activation of the innate immunity is the 
recognition of the pathogen that is done through Pathogen-Recognition 
Receptors (PRR) that recognise Pathogen-associated Molecular patterns 
(PAMP)21 on the surface of innate immune cells. PAMP are molecules that 
are not produced by eukaryotic cells, possess invariant structural features 
and are necessary for the microbe’s survival. Their recognition by PRR is 
hence advantageous for the host. There are several PRR that evolved in 
order to interact with different PAMPs; among them, there is a receptor that 
is specialized in the recognition of LPS. 
 
 1.4.2. TLR4/MD-2 receptorial complex and 
inflammation 
 Firstly discovered in Drosophila, the Toll protein was known to 
control dorsal-ventral patterning in embryon and inflammatory response in 
adults. Its analogue was later on discovered in humans as a 
transmembrane protein related to NF-κB signaling22. Those proteins are 
now referred as Toll-like receptors (TLRs) and known to be part of human’s 
innate immunity. To better fight infection, there are several types of TLRs 
that can each recognize a particular PAMP. For example, TLR2 interacts 
with lipoprotein and TLR5 with flagellin. 
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The first discovered TLR was TLR4 that was shown to specifically 
interact with LPS23. Further studies proved that TLR4 does not work alone. 
The presence of another protein, the Myeloid Differentiation factor 2 (MD-2) 
is necessary to respond to LPS infection24. MD-2 is associated to the extra-
cellular domain of TLR4 and together they form the TLR4/MD-2 receptorial 
complex. Further studies enhanced the comprehension of TLR4/MD-2 
activation and its related signalling pathway. LPS is firstly recruited by LPS 
Biding proteins (LBP) and is further transferred to the TLR4/MD-2 receptor 
through CD14. All those interaction spontaneously happen due to the 
existence of a thermodynamic funnel that prone the assembly of those 
molecules25.  
Once LPS is linked to TLR4/MD-2, it triggers the dimerization of the 
receptorial complex and further intra-cellular signalling. In brief, two main 
supramolecular structures can be formed after the dimerization, triggering 
different inflammations pathways26 (Figure 8). When the Toll/interleukin-1 
Receptor domain-containing Adaptor Protein (TIRAP) and Myeloid 
Differentiation primary response protein 88 (MyD88) are linked to the 
intracellular part of TLR4, an assembly called the Myddosome is formed. 
Further association with Interleukin-1 Receptor Associated Kinase (IRAK) 
triggers cytokine production with the activation of transcription factors that 
are Nuclear Factor-κB (NF-κB) and Activator Protein 1 (AP1). The second 
supramolecular complex, the Triffosome, is MyD88-independent and 
involves the assembly of TIR domain-containing adaptor protein inducing 
IFNβ (TRIF) and TNF receptor-associated factor 3 (TRAF-3). It activates 
NF-κB, AP1 and also interferon regulatory factor 3 (IRF-3). All the recruited 
transcription and regulatory factors can then modulate the expression of the 
host genome, leading to the inflammatory response27. 
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Figure 8: General description of TLR4/MD-2 signalling pathway  
 
 Inflammation is a physiological phenomenon that is necessary for the 
organism to protect itself. However, a dysregulation can lead to major 
deceases. Sepsis and septic shock are disorders that arise from an 
unbalanced inflammatory response. Those are significant cause of death 
among developed countries28. Better understanding TLR4/MD-2 
mechanism and finding new regulators is essential to develop therapies. In 
this context, many bioactive compounds have been tested in order to 
modulate the innate immunity29. As natural activators of TLR4/MD-2, LPS 
play a key role in the exploration of new modulators. It is now widely known 
that the interaction between TLR4/MD-2 and LPS is driven by a structure 
dependent relationship. 
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 1.4.3. Structure and function relationship 
 The idea that LPS structure would influence its endotoxic activity was 
already investigated 25 years ago30. The study of Lipid As conformation 
from several gram-negative bacteria lead to observation of a correlation 
between their three-dimensional structures and biological activity. Indeed, 
the Lipid A toxicity potency is linked to a non-lamellar supramolecular 
structure. Further researches confirmed the relationship between LPS 
shape and biological activity. The degree of acylation of the Lipid A and the 
length of its fatty acids influence its three-dimensional conformation. When 
the Lipid A has a high degree of acylation, as the hexa-acylated Lipid A 
from E. coli, it adopts a conical shape. Penta-acylated Lipid A, e.g. from P. 
gingivalis, have an intermediate shape and hypo-acylated Lipid As, as 
biosynthetic precursors Lipid Ia and Lipid IVa, adopt a strictly cylindrical 
shape (Figure 9)31.  
 
 
Figure 9: Three dimensional conformations of Lipid A with different degree of acylation31 
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It is known that E. coli LPS possesses a strong agonist activity 
towards TLR4/MD-2 receptorial complex and P. gingivalis LPS activity is 
less TLR4-dependent32. Lipid IVa has been identified as a slight agonist in 
mice and an antagonist towards human MD-233. All those data confirm that 
conical supramolecular structures are correlated to agonist activity and 
cylindrical shapes to antagonist. Crystal structure of Lipid IVa linked to 
human MD-2 showed that all fatty acids of the antagonist Lipid A are 
inserted in the MD-2 binding pocket34, and that this did not modify the 
conformation of MD-2. The interaction between E. coli agonist Lipid A and 
TLR4/MD-2 was also investigated by crystallography35. When the hexa-
acylated Lipid A interacts with MD-2, one of its fatty acid does not enter the 
hydrophobic pocket and remains on the protein surface (Figure 10). The 
exposed fatty acid can then interact with the hydrophobic region of a 
second TLR4. As for Lipid IVa, the insertion of E. coli LPS in MD-2 does not 
change the size of the hydrophobic pocket. However, the di-glucosamine 
backbone of E. coli LPS adopts a different spatial conformation, compared 
to Lipid IVa. Such orientation of the Lipid A makes its phosphates groups 
interact with positively charged residues of both TLR4. This interaction, 
combined to hydrophilic and hydrophobic contacts, are crucial in order to 
generate the dimerization of TLR4/MD-2. Indeed, the fatty acid of E. coli 
Lipid A that is at the surface of the hydrophobic pocket can interact with two 
TLR4s, whereas Lipid IVa does not have fatty acid that mediates the 
heterodimer formation (Figure 10). As the dimerization of the receptorial 
complex is necessary for triggering an inflammatory response, those 
interactions explains why E. coli LPS has a strong agonist activity and Lipid 
IVa is an antagonist.   
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Figure 10: Representation of the interaction between E. coli Lipid A (A), Lipid IVa (B) and 
TLR4/MD-2 receptorial complex. Orientation of E. coli Lipid A triggers the dimerization of 
the receptor 
 
Finally, Lipid IVa was also studied with murine MD-236. It was shown 
that the different amino acids present in the hydrophobic pocket made the 
Lipid IVa adopt the same overall conformation than E. coli LPS. That 
explains the slight agonist activity of Lipid IVa in mice. Interactions between 
endotoxins and TLR4/MD-2 were studied not only by crystallisation but also 
using other techniques. A more recent investigation of LPS-TLR4 
interaction was done by Single Molecule Localisation Microscopy 
(SMLM)37. With this technique, it was possible to detect monomeric and 
dimeric TLR4 molecules in presence of various LPS. In presence of LPS 
from E. coli and S. minesotta, most of TLR4 were detected in dimeric forms 
but in presence of LPS from R. sphaeroides, TLR4 remained in monomeric 
state.  
Thus, the whole structure of the LPS may influence the interaction. 
Indeed, a lot of work have been dedicated to the Lipid A but other 
constituents, as the Kdo or heptoses of the core oligosaccharide, contribute 
to the biological activity38. In this context, discovering novel LPS structures 
is necessary to find new modulators for TLR4/MD-2 receptorial complex. 
Exploring particular environment where bacteria have specific adaptation 
strategy is a promising way to detect interesting molecular features.  
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1.5. Lipopolysaccharides from marine and extreme 
environment 
 
1.5.1. Life at the extreme  
From a human perspective, the optimal conditions for life are at 
neutral pH, temperature between 20 and 40 °C and at atmospheric 
pressure. However, life can also exist in conditions that are considered as 
hostile for many life forms. Organisms living in such conditions are termed 
extremophiles and their fascinating properties were studied for decades39. 
Extremophiles can be classified in several categories depending on the 
conditions in which they thrive. For example, psychrophiles can live below 
15 °C and thermophiles above 60 °C, barophiles can support up to 80 
MPa and halophiles can live in salinity environment with saturated NaCl 
(Figure 11). Some organisms are able to survive in several extreme 
conditions, as high pressure and high temperature, and are termed 
polyextremophile. There is still a lot to discover about extremophiles and 
current metagenomic analysis lead to the discovery of extremophiles new 
genus and species and a better understanding of their metabolism40. The 
study of extremophiles is also appealing for biotechnology. Indeed, those 
organisms can produce metabolites with unique properties that are studied 
for industrial applications41. Extremophiles Gram-negative bacteria also 
possess LPS on their OM and those molecule can have particular 
properties.  
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Figure 11: Representation of extremophiles diversity in different environments 
 
1.5.2. LPS structures from marine bacteria and 
extremophiles 
The ocean is the place where life could be created and it still 
includes a countless diversity of organisms. Marine microorganism adapted 
to their environment by creating a various number of metabolites. Their 
study lead to the discovery of bio-active compounds with large therapeutic 
interest, as anti-bacterial, anti-fungal and anti-tumoral molecules42. In 
particular, Gram-negative marine bacteria are omnipresent organism whose 
LPS can possess interesting immunological activity. Indeed, specific 
structural features can be observed in these environments43. O-antigen and 
core oligosaccharides of marine LPS are usually negatively charged with 
the presence of uronic acids and non-glycosidic substituents. As LPS are 
constantly exposed to the marine environment, the anionic residues links to 
the surrounding cations, strengthening the global membrane structure. This 
mechanism provides the bacteria higher stability towards its environment. 
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Several Lipid A from marine bacteria were also characterized and common 
features were observed. Short fatty acids – in comparison to E. coli Lipid A- 
are often found in marine bacteria with Lipid A containing 10 to 13 carbon 
acyl moieties. Marine bacteria also possess low acylated (penta and tetra-
acylated) and phosphorylated (mono-phosphorylated) Lipid A. Those 
characteristic are associated with low-agonist and antagonist activity and 
encourage the exploration of new endotoxin structures in the oceans.  
As a consequence of their adaptation, extremophiles also possess 
LPS with interesting structures44. As for marine bacteria in general, 
extremophiles often possess negatively charged O-antigen and their Lipid A 
usually have shorter acyl chains (Figure 12)45,46,47. They are a promising 
source of agonist and antagonists towards the TLR4/MD-2 receptorial 
complex. Characterizing LPS from bacteria that live in marine and extreme 
conditions is hence necessary in order to understand their adaptation 
process and to find new modulators of the innate immune system. 
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Figure 12: Structure of Lipid As from some marine and extremophile bacteria: (A) 
Alteromonas aldita, a marine bacterium (B) Halomonas patelleriensis, an haloalkaliphilic 
bacterium (C) Thermomonas hydrothermalis, a thermophile 
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Chapter 2: Characterization of 
Lipopolysaccharides 
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2.1. Extraction and purification of 
Lipopolysaccharides 
 
Extraction of LPS is the first step towards its structural elucidation. 
Two main procedures have been designed in order to isolate LPS. The first 
one is the PCP extraction in which bacterial cells are exposed to a mixture 
of Phenol/Chloroform/Petroleum ether (5:8:2). This methods is more 
suitable for the extraction of LOS as the extracted material can be found in 
the phenol phase. The other procedure is the Hot Phenol-Water 
extraction48, in which the extraction is more convenient for LPS as they can 
be isolated in the aqueous phase. The extracted material is usually impure 
after this procedure. Indeed, cells contaminants such as proteins and 
nucleic acids can be also found in the same aqueous phase. In order to 
remove contaminants and purify the extracted material, the sample is 
further purified using an enzymatic treatment with several enzymes 
(Proteases, DNAses and RNAses); the sample then undergoes several 
Ultra-centrifugation or Size-Exclusion chromatography steps (Figure 13).  
Once the extract is lyophilised, electrophoretic methods as Sodium 
Dodecyl-Sulfate polyacrylamide gel (SDS-PAGE) and Sodium 
Deoxycholate Polyacrylamide gel (DOC-PAGE) are performed. The use of 
subsequent silver staining procedure allows the detection of the LPS/LOS 
by revealing its saccharidic portion49. If the extract is an LOS, a large band 
is detected at the bottom of the gel. If it is an LPS, a ladder-like pattern is 
seen in the middle of the gel, showing the bacteria O-antigen length 
diversity. Performing electrophoresis with silver staining is a necessary step 
in the characterization of endotoxin structures. Indeed, typical stains 
provide a solid validation of the LPS/LOS nature of the extract. 
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Figure 13: Usual procedure used for the extraction and purification of LPS and LOS 
 
 
2.2. Chemical analysis of Lipopolysaccharides 
 
 GC-MS analysis of carbohydrate and fatty acids derivatives provide 
crucial information about the composition of the extracted and purified LPS. 
Several methods can be used in order to determine the carbohydrate 
composition of the core oligosaccharides and the O-antigen50. The first one 
is the Acetylated Methyl glycoside (MGA) procedure. This methods gives 
information about the nature of the monosaccharides present in the LPS. 
An aliquot of the extract is methylated at anomeric position in acidic 
conditions and then per-acetylated. The obtained derivatives are then 
analysed by GC-MS with a standard that is per-acetylated inositol. The 
nature of each monosaccharide is given by their retention time on the 
chromatogram combined with their MS data.  
Once the monosaccharide composition of the LPS is assessed, their 
branching points are determined using the Partially Methylated Alditols 
Acetates (AAPM) method. In the present procedures, the polysaccharide is 
methylated at free hydroxyl positions in basic condition with further 
treatment by iodomethane (CH3I)51. The linkages are then cleaved with 
Trifluoroacetic acid (TFA). A reduction with Sodium Borodeuteride (NaBD4) 
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is then performed. This step is crucial because it leads to the ring opening 
and marks the anomeric position with deuterium atoms. The sample is then 
acetylated at its remaining free hydroxyls groups (Figure 14). The obtained 
monosaccharides derivatives are finally injected on GC-MS. It should be 
noted that with the present procedure, carbohydrates containing carboxylic 
acids (as uronic or ulosonic acid) cannot be detected. In order to analyse 
those monosaccharides, it is necessary to first reduce the carboxylic acid 
group before performing the hydrolysis with TFA (Figure 14). As for MGA, 
the determination of the branching points is done by analysing their 
retention time on the GC chromatogram and their fragmentation by MS. 
 
 
 
Figure 14: Protocol used for the AAPM derivatisation of carbohydrates 
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Fatty acid content of the LPS can also be analysed by GC-MS52. An 
aliquot of the LPS is methylated as described for the MGA procedure and 
then extracted with hexane. The obtained methyl-ester derivatives are then 
injected on GC-MS. Each fatty acid has a specific retention time and 
fragmentation pattern. It is hence possible to determine the composition of 
the sample by detecting fatty acids with different acyl chain length, 
hydroxylation and unsaturation.  
Compositional analysis give crucial data for the structural analysis of 
the LPS. However, they are not sufficient to achieve the characterization of 
the exact structure. Different methods have to be used on the saccharidic 
part and the Lipid A. Several chemical treatments can be performed in 
order to separate and isolate those two moieties. 
 
2.3. Isolation of poly- and oligo-saccharide and Lipid 
A portions 
 
 The Kdo is a particular monosaccharide that is most of the times 
found between the non-reducing glucosamine of the Lipid A and the core 
oligosaccharide. Due to the presence of carboxylic acid at anomeric 
position and the lack of hydroxyl substituent at its C3 position, it is highly 
labile in acidic position. This is a useful property when the Lipid A needs to 
be separated from the saccharidic moiety. When the LPS is treated in mild 
acidic conditions, a cleavage occurs between the non-reducing 
glucosamine of the Lipid A and the Kdo. The polysaccharide and Lipid A 
are then easily separated by centrifugation. 
 Another methods can be used for the isolation of the saccharide 
portion. It is the full deacylation of the LPS53. This procedure is typically 
used to separate the Lipid A from the core Oligosaccharide. In a first step, 
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the sample is treated with hydrazine (N2H4), removing the O-linked acyl 
chains. Then a treatment in basic condition (using KOH) cleaves the 
remaining N-linked acyl chains. After desaltation and purification by column 
chromatography, the isolated oligosaccharide is ready to be fully 
characterized. 
 
2.4. NMR of poly- and oligo-saccharides 
 
 Nuclear Magnetic Resonance (NMR) is a non-destructive technique 
that give information on the different nuclei present in a molecule and their 
atomic environment. There exist many NMR experiments that provide 
complementary data for structural characterization of polysaccharides54. 1H 
NMR experiment is a 1D spectrum where signals corresponding to each 
protons of the polysaccharides are recorded. Many information can be 
assessed with this experiment. Indeed, each region of the spectrum 
corresponds to a specific kind of proton. Anomeric protons are visible 
between δ 4.6 and 5.5 ppm, acetyl groups between δ 2.0 and 2.2 ppm and 
methyl groups between δ 1.0 and 1.3 ppm. Remaining protons are found in 
the bulk region between δ 2.6 and 4.6 ppm.  
1H NMR spectrum can also be used in order to measure anomeric 
coupling constant and hence determine each monosaccharide 
configuration. Indeed, 3JH1-H2 is around 7-9 Hz for α-configured and 1-4 Hz 
for β-configured carbohydrates like glucose and galactose, respectively due 
to diaxial and equatorial-axial couplings. For D-mannose, different values 
are measured as its H2 is equatorial. Its β-configuration correspond to a 
3JH1-H2 around 1-2 Hz and α-configuration around 0-1 Hz. 
 To go deeper in the analysis, several 2D spectra must be recorded. 
Correlation Spectroscopy (COSY), and Total Correlation Spectroscopy 
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(TOCSY) are homonuclear through-bond experiments. Both of the axis in 
the spectra correspond to the same kind of atom (1H) and the 
magnetization transfer is performed through bounds connections. Those 
experiments hence measure the correlations of protons among the same 
monosaccharide unit. All protons from a given unit hence belong to the 
same spin system. In COSY experiment, observed cross-peaks emerge 
from magnetization transfer to direct neighbours. This is convenient for the 
attribution of the precise proton sequences among the same spin system. 
TOCSY experiment give additional information by transferring the signal 
through several connections. The two previously described experiments 
allow the assignment of proton sequence within the same unit but do not 
give any information about the linkages between each monosaccharides. 
Nuclear Overhauser Spectroscopy (NOESY) is a homonuclear through-
space experiment. Contrary to COSY and TOCSY, the magnetisation is 
transferred to proton that are spatially closed. With this experiment, it is 
hence possible to detect a correlation between an anomeric proton and the 
proton of the other unit to which it is linked (Figure 15). 
 Other structural data can be assed using heteronuclear 2D 
experiments. Heteronuclear Single-Quantum Correlation Spectroscopy 
(HSQC) shows correlations between carbons and protons that are directly 
linked. As for proton spectra, HSQC can be divided in different region in 
which the carbon chemical shift is characteristic of its environment. 
Anomeric carbon are usually found between δ 90-110 ppm, nitrogen-
bearing carbons between δ 45-60 ppm, methyl groups around δ 10-20 ppm 
and sugar ring carbons between δ 60-80 ppm. Heteronuclear Multiple Bond 
Correlation (HMBC) gives signals between 13C and 1H that are correlated 
through several bounds (Figure 15).  
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Figure 15: Representation of atom interactions with different 2D NMR experiments 
 
2.5. Mass Spectrometry of the Lipid A 
 
 Mass Spectrometry (MS) is a technique that give information about 
molecular mass. It is a destructive methods that have the advantage to 
work with very little amount of sample. Several ionisation and fragmentation 
techniques can be used in MS. For big molecules, as peptides or Lipid A, 
MALDI ionisation coupled with Time Of Flight (TOF) separation is a suitable 
technique that is often used. MALDI/TOF MS of Lipid A can be recorded 
either in positive or negative ion mode.  
Negative ion MALDI/TOF MS of Lipid A extracted in acidic conditions 
contains several clusters of peaks corresponding to species with different 
degree of acylation. Indeed, under-acylated species can be formed after 
mild acid hydrolysis and there can also naturally occur a mixture of Lipid A 
species in intact cells. The mass difference between each clusters usually 
corresponds to an acyl chain or a phosphate. The composition of the Lipid 
A, i.e. its phosphorylation, the number and nature of its acyl chains and the 
presence of other substituents, can be determined with this experiment. 
   
34 
 
However, MALDI/TOF MS analysis alone is not sufficient to obtain a 
detailed structure. Indeed, it is not possible with this technique to determine 
the linkage position of each phosphates and acyl chains on the di-
glucosamine backbone. MS/MS analysis are then performed on several 
precursor ions. The fragmentation of the studied Lipid A species are 
analysed with those experiments. Those fragments can arise from the loss 
of phosphates and fatty acids but also from sugar ring and linkage 
cleavage. Those well-known events possess a specific nomenclature that 
was determined by Costello et al.55 (Figure 16). The occurrence of those 
linkages and sugar ring fragmentation allow the detection of mass 
corresponding to each glucosamine. This experiment is hence necessary in 
order to establish the acyl chains repartition among the di-glucosamine 
backbone. 
 
 
 
Figure 16: Main linkages and sugar ring fragmentation that can be observed during 
MS/MS of the Lipid A 
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Finally, the Lipid A should undergo an ammonium treatment to 
complete its structural analysis. Indeed, this procedure is necessary in 
order to determine if each acyl moieties in ester or amide-linked56. It is 
known that with this method secondary ester-linked are more labile than 
primary ester-linked acyl moieties and amide linked residues. MALDI/TOF 
MS performed after such extraction procedure hence lead to the detection 
of species which mass difference correspond to their ester-linked fatty 
acids. The analysis can be completed with MS/MS of ammonium treated 
Lipid As. The combination of all previously described MS experiments lead 
to the precise determination of the Lipid A architecture.  
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Section II 
Pseudoalteromonas sp1A1: 
From endotoxin to Outer-
Membrane 
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Chapter 3: Structure and activity of 
Lipopolysaccharide of 
Pseudoalteromonas sp 1A1 
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3.1. Pseudoalteromonas spp. and their environment 
 
The genus Pseudomonas is part of the ‘gamma-proteobacteria’ 
group and is composed of gram-negative aerobic and flagellated bacteria57. 
Based on 16S rRNA analysis, Gauthier et al. proposed a division of this 
group with the new genus Pseudoalteromonas58. Since then, 
Pseudoalteromonas spp. is widely studied for its capacity to produce 
biologically active molecules such as antibiotics and compounds against 
fungi59. These properties give Pseudoalteromonas spp. the ability to survive 
and coexist in its complex environment60. It can indeed significantly 
influence its ecosystem with several mechanisms as the production of 
biofilms, anti-fouling and anti-algae agents61.  
Pseudoalteromonas spp. encloses several marine species, some 
known to interact as symbiont or pathogens with eukaryotic organisms 
including marine sponges62. Within this ecosystem, sponges developed 
molecular strategy to recognize and defend themselves against pathogenic 
microbes, as the case of Suberites domuncula which developed a 
molecular immune response towards bacterial infection63. As gram-negative 
bacteria, Pseudoalteromonas spp possess LPS in their OM (See Section 
1). The LPS isolated from different Pseudoalteromonas strains were shown 
to be penta-acylated with low-immunostimulatory and antagonist properties 
in murine cells64. For S. domuncula, LPS is recognized by a specific 
receptor named S. domuncula LPS interacting protein (SLIP) and then 
activates the MyD88-dependent pathway of TLR4/MD-2 receptorial 
complex65.  
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The present chapter reports the investigation of the structure and 
immunological activity of the LPS from Pseudoalteromonas sp1A1. It is a 
sponge-pathogen bacterium isolated from S. domuncula66. Further analysis 
of the properties of the LPS were made in order to understand 
Pseudoalteromonas sp1A1 behaviour in its ecosystem and to dissect its 
immunopotential. 
 
3.2. Extraction and compositional analysis  
 
The LPS was extracted using hot phenol-water procedure and 
purified by enzymatic treatment. SDS-PAGE confirmed the presence of 
LPS in the purified water phase with the occurrence of a ladder-like pattern 
on the gel (Figure 17).  
 
 
A    B 
 
Figure 17: SDS-PAGE 13.5% A. LPS from E. coli standard; B. LPS from 
Pseudoalteromonas sp1A1, water phase 
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Compositional analysis (MGA) showed the presence of D-3-deoxy-3-
amino-Quinovose (D-QuiN), D-Mannose (D-Man), D-Glucose (D-Glc), D-
Glucosamine (D-GlcN), 3-deoxy-D-manno-oct-2-ulopyranosonic acid (D-
Kdo) an another Ulosonic acid identified as 3-deoxy-D-glycero-D-galacto-
nonulosonic acid (KDN)67 (Figures 18 and 19). Combined with previous 
MGA experiment, AAPM analysis showed that Pseudoalteromonas sp1A1 
LPS is composed of terminal Qui3N, terminal Man, 4,6-subsituted-Glc, 3-
substituted-GlcN and 3,4,6-substituted-GlcN. 
 
 
Figure 18: GC-MS chromatogram of MGA derivative of Pseudoalteromonas sp1A1 LPS 
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Figure 19: Structure of as 3-deoxy-D-glycero-D-galacto-nonulosonic acid (KDN) 
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Fatty acid analysis revealed the occurrence of (R)-3-
hydroxydodecanoic acid [12:0(3-OH)], (R)-3-hydroxydecanoic acid [10:0 (3-
OH)], (R)-3-hydroxyundecanoic acid [11:0 (3-OH)], (R)-3-
hydroxytridecanoic acid [13:0 (3-OH)] as primary acyl chains, both in amide 
and ester linkage, and, as secondary acyl chain, of dodecanoic acid (12:0), 
decanoic (10:0), undecanoic acid (11:0), tridecanoic acid (13:0), 
dodecenoic (12:1) and tridecenoic (13:1).  
 
3.3. Structure of Pseudoalteromonas sp 1A1 O-
antigen 
 
Pseudoalteromonas sp1A1 LPS was fully de-acylated and its O-
antigen was characterised via NMR spectroscopy. A combination of homo- 
and heteronuclear 2D NMR experiment (DQF-COSY, TOCSY, ROESY, 
NOESY, 1H-13C HSQC, 1H-13C HMBC) was executed to assign all the spin 
systems and to define the saccharidic sequence. Complete assignment of 
the spin systems was obtained attributing the proton resonances by DQF-
COSY and TOCSY spectra, and subsequently correlating each proton to its 
related carbon atom through the HSQC spectrum. The anomeric 
configuration of each monosaccharide unit was assigned on the basis of 
3JH-1,H-2 coupling constant obtained by the DFQ-COSY.  
A magnitude of 3JH-1,H-2  with values of 7–9 Hz was associated with 
the diaxial coupling of a  β-configured sugar unit, whereas 2–4 Hz was 
indicative of an equatorial-axial coupling of  
α-configured residues. Six different units were detected in 
Pseudoalteromonas sp1A1 O-antigen (Figure 20). 
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Figure 20: 1H spectra of deacylated O-antigen from Pseudoalteromonas sp1A1 
 
 
Unit 1 2 3 4 5 6 7 8 9 
A 
α-GlcN 
5.18 
99.37 
2.80 
56.21 
3.54 
80.66 
3.29 
74.67 
4.04 
72.57 
3.63-
3.51 
64.01 
-- -- -- 
B 
α-Glc 
5.13 
99.18 
3.36 
72.96 
3.51 
72.57 
3.17 
69.60 
3.61 
72.26 
3.65-
3.52 
60.47 
-- -- -- 
C 
α-Man 
5.00 
97.97 
3.58 
72.10 
3.47 
71.10 
3.23 
69.99 
3.365 
71.71 
3.69-
3.52 
60.70 
-- -- -- 
D 
β-GlcN 
4.51 
98.31 
2.62 
55.87 
3.36 
84.0 
3.27 
75.76 
3.43 
69.54 
3.78-
3.82 
56.94 
-- 1.24 24.37 -- 
E 
β-
Qui3N 
4.43 
103.41 
3.10 
72.80 
2.67 
57.26 
2.84 
73.89 
3.35 
69.15 
1.07 
16.65 -- -- -- 
F 
KDN -- -- 
1.72-
1.98 
34.6 
3.99 
65.53 
3.83 
73.5 
4.11 
69.77 
4.03 
62.7 
3.40 
85.72 
3.65-
3.41 
64.01 
 
Table 1: 1H and 13C (italic) chemical shifts (ppm) of de-acylated O-antigen from 
Pseudoalteromonas sp1A1 
 
Spin systems A, B, D, E were gluco-configured residues as indicated 
by the large 3JH,H ring coupling constant values of their ring protons (8-
10Hz). Residues A and D (H1 respectively at δ 5.18 ppm and δ 4.51 ppm, 
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table 1) were identified as α-GlcN and β-GlcN based on their nitrogen-
bearing C-2 respectively at δ 56.21 and δ 55.87ppm. Residue B was 
recognized as α-Glc (H1 at δ 5.13ppm, table 1). Residue E was identified 
as β-Qui3N according to the value of its C-3 (δ 57.26 ppm) indicative of a 
nitrogen-bearing carbon and its downfield H-6/C-6 (δ 1.07/16.65 ppm) 
corresponding to the methyl group.  
Residue C (H1 at δ 5.00ppm, table 1) was attributed as α-mannose. 
The manno configuration was established by 3JH-1,H-2  and 3JH-2,H-3 values 
(below 3 Hz), the α-configuration was assigned either by the intra-residual 
NOE contact of H-1 with H-2 and by chemical shift value of its C1 (δ 97.97 
ppm, table 1). Finally, residue F was identified as KDN, in accordance with 
the compositional analysis. Indeed, it possesses characteristic 
diastereotopic methylene signals at H-3 (δ 1.72/1.98 ppm, table 1) and a 9-
carbon sequence.   
Moreover, the proton at 1.24 ppm (with corresponding carbon at δ 
24.03 ppm) gave NOE contacts with protons H-4 (δ 3.27 ppm) and H-6 (δ 
3.78-3.82 ppm) of unit D. It was attributed to a methyl group of a pyruvate 
that is linked to the β-GlcN.  
 
 
Figure 21: NOESY (black) and TOCSY (grey) spectra of the anomeric region of the O-
antigen of Pseudoalteromonas sp1A1 
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NOESY (Figure 21) and HMBC spectra allowed the determination of 
the sugar sequence in the polysaccharide and was consistent with previous 
compositional analysis.  Spin system F was substituted at O-5 by residue A 
and O-7 by residue D, as shown by NOE contacts found between H-1 A (δ 
5.18 ppm) and H-5 F (δ 3.83 ppm) and between H-1 D (δ 4.51 ppm) and H-
7 F (δ 4.03 ppm). Spin system A was in turn glycosylated by residue E as 
indicated by NOE contact between H-1 E (δ 4.43 ppm) and H-3 A (δ 3.54 
ppm). Spin system D was substituted at O-3 by residue B as shown by 
NOE correlations between H-1 B (δ 5.13 ppm) and H-3 D (δ 3.36 ppm). 
Finally, spin system B was glycosylated at O-3 by residue C as proven by 
NOE contacts between H-1 C (δ 5.00 ppm) and H-3 B (δ 3.51 ppm) (Figure 
21). Combined with previous methylation analysis, the full sequence of 
Pseudoalteromonas sp1A1 O-antigen was elucidated as a branched 
polysaccharide and its structure is represented in Figure 22. 
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Figure 22: Structure of the O-antigen from Pseudoalteromonas sp1A1 
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3.4. Structure of Pseudoalteromonas sp1A1 Lipid A 
 
Negative-ion MALDI-TOF MS of Pseudoalteromonas sp1A1 was 
performed on the mild acid hydrolysis product and is shown in Figure 23. 
The very heterogeneous composition of the Lipid A could be clearly seen, 
in accordance to previous compositional analysis and other 
Pseudoalteromonas spp. LPS Lipid A species68,69,70.. The mass spectrum 
showed multiple sets of pseudomolecular ion peaks [M-H]- comprised in the 
mass range m/z 1000-1500 Da (Figure 23). Within those clusters, the 
occurrence of mass differences of 14 amu was attributable to methylene 
units and thus referred to Lipid A species having different acyl chain 
lengths.  
 
 
Figure 23: Negative-ion MALDI-TOF mass spectrum of the isolated lipid A fraction from 
Pseudoalteromonas sp 1A1 LPS. Assignment of the lipid A species as Tri LA (tri-acylated 
lipid A species), Tetra LA (tetra-acylated lipid A species), Penta LA (penta-acylated lipid A 
species) and the relative groups of ions lacking one phosphate is also indicated 
 
The bis-phosphorylated and penta-acylated species were detected in 
the cluster around m/z 1474.6 (Figure 23), this last corresponding to a lipid 
A species carrying four 12:0 (3-OH) primary acyl substituent and one 12:0 
as secondary acyl moiety. The species at m/z 1446.6 matched with a lipid A 
containing two 12:0 (3-OH), one 11:0 (3-OH), one C10:0 (3-OH) and one 
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C13:0. Its corresponding mono-phosphorylated lipid A could be detected at 
m/z 1366.6 (Δm/z = 80). Fragments at m/z 1276.4 and 1262.4 matched 
with tetra-acylated species that have respectively lost C12:0 (3-OH) or 
C11:0 (3-OH) moieties (Figure 23, Table 2). The most abundant peak, at 
m/z 1196.4, corresponded to a mono-phosphorylated and tetra-acylated 
Lipid A species bearing three 12:0 (3-OH) and one 12:0 (Figure 23, Table 
2). 
 
 
Table 2: Proposed interpretation of main peak ions of MALDI-TOF MS (Figure 23) 
 
 Pseudoalteromonas sp 1A1 hence possesses the same mixture of 
Lipid A species that are represented on Figure 24. The bis-phosphorylated 
and penta-acylated Lipid A species is acylated by four C12:0 (3-OH) in 
amide linkages and as primary ester-linked fatty acids and one C12:0 as 
secondary fatty acid. The other penta-acylated Lipid A species is also bis-
phosphorylated and penta-acylated and possesses one C10:0 (3-OH), one 
C11:0 (3-OH) and one C12:0 (3-OH) as primary linked fatty acid and one 
C13:0 as secondary linked fatty acid. It should be noted that odd numbered 
fatty acids – C11:0 (3-OH) and C13:0 – likely possesses isopropyl groups 
Observed ion 
peak (m/z) 
Acyl 
Substitution Proposed Fatty acid/phosphate composition 
1474.6 Penta-acyl HexN2P2 [C12:0 (3OH)]4[C12:0] 
1446.6 Penta-acyl HexN2P2[C12:0 (3OH)]2[C11:0 (3OH)] [C10:0 (3OH)] [C13:0] 
1366.6 Penta-acyl HexN2P[C12:0 (3OH)]2[C11:0 (3OH)] [C10:0 (3OH)] [C13:0] 
1276.4 Tetra-acyl HexN2P2 [C12:0 (3OH)]3[C12:0] 
1262.4 Tetra-acyl HexN2P2 [C12:0 (3OH)]2[C10:0 (3OH)] [C13:0] 
1248.4 Tetra-acyl HexN2P2[C12:0 (3OH)][C11:0 (3OH)] [C10:0 (3OH)] [C13:0] 
1196.4 Tetra-acyl HexN2P[C12:0 (3OH)]3[C12:0] 
1182.4 Tetra-acyl HexN2P[C12:0 (3OH)]2[C10:0 (3OH)] [C13:0] 
1014.2 Tri-acyl HexN2P [C12:0 (3OH)]3 
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at their extremity. The obtained data are in accordance with the study of 
Pseudoalteromonas sp 2A, a commensal bacterium also isolated from S. 
domoncula71. 
 
 
Figure 24: Structure of Pseudoalteromonas sp1A1 Lipid A species 
 
Gardères et al.66 previously analysed Pseudoalteromonas sp 1A1 
Lipid A and found mono-phosphorylated and penta-acylated Lipid A 
species, bearing four 12:0 (3-OH) one 12:0 units. However, they did not 
detected the bis-phosphorylated species and concluded that the secondary 
fatty acid on the non-reducing glucosamine was linked on the acyloaxyl 
ester instead of the acyloxyamide. They possibly detected fragments of the 
lipid A that got degraded.  
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3.5. Structure of Pseudoalteromonas sp 1A1 LOS 
 
The full LOS structure has also been resolved using MALDI-TOF MS 
(Figure 25). Clusters corresponding to the native LOS could be seen 
between m/z 2300 and 3000. In source regiospecific cleavage (β-
elimination) of the labile linkage involving the Kdo enables both the 
detection of the core oligosaccharide ions (B-type ions, m/z 1000-1200) and 
the Lipid A ions (Y ions, m/z 1400-1500)72. Several species were detected 
in the higher mass region, corresponding to the native LOS composed by 
the Lipid A with four C12:0 (3-OH) and one C12:0 (Figure 24). Peak at m/z 
2531.7 was attributed to the LOS with a core oligosaccharide composed of 
one Kdo, one heptose and three hexoses. The minor peak at m/z 2369.7 
corresponded to the LOS that lacks one hexose unit. Another LOS species 
constituted by four hexoses was detected at m/z 2693.6. The ion at m/z 
2487.7 originated from the loss of a neutral CO2 on the Kdo unit. Finally, the 
minor peak at m/z 2423.5 was attributed to the native LOS devoid of a 
phosphate group and constituted by the Lipid A with one C10:0 (3-OH), one 
C11:0 (3-OH), two C12:0 (3-OH) and one C13:0 (Figure 24). 
The main Pseudoalteromonas sp1A1 core oligosaccharide is 
composed of three hexoses, one heptose, the Kdo and two phosphates. 
The hexoses comprise one terminal glucose, one terminal galactose and 
one 4-substituted galactose. The heptose is 4,7-substituted and possesses 
a phosphate group at its 3-position. Finally, the Kdo is 5-substituted and 
possesses another phosphate group at its 4-position (Figure 26). Those 
data match the analysis of another Pseudoalteromonas strain that present 
the very similar LOS structure73. 
 
   
49 
 
 
Figure 25: MALDI TOF MS analysis of total LOS from Pseudoalteromonas sp1A1; Zoom 
on the whole LOS fragmentation is reported in the inset 
 
Figure 26: Structure of Pseudoalteromonas sp1A1 LOS 
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3.6. Immunological assays  
 
Biological assays were performed to determine the effect of 
Pseudoalteromonas sp 1A1 on mammal’s innate immune system. This 
work was performed within Prof. Bayeart’s team at VIB, Ghent, Belgium. 
Human homocytic cell line THP1 was used to test agonist activity. Cells 
were stimulated with different concentrations of Pseudoalteromonas sp1A1 
and E. coli LPS or were left untreated. The quantity of secreted TNF was 
measured by ELISA. Results shows that, although a slight immunostimulant 
effect can be observed, Pseudoalteromonas sp1A1 do not possess 
interesting agonistic activity compared to E .coli LPS (Figure 27 a).  
Antagonist activity of Pseudoalteromonas sp1A1 lipid A was 
assessed with a competitive test. The experiment was performed with Raw-
Blue-hTLR4 murine cell line. Treatment with E. coli LPS and untreated cells 
were used as control. After incubation of cells with 100 ng/mL of E. coli LPS 
and different concentrations of Pseudoalteromonas sp1A1 LPS, Secreted 
Alcaline Phophate (SEAP) was measured by absorbance. Its concentration 
is directly linked to the immunostimulant activity of the tested compound or 
its mixture. The results demonstrates that Pseudoalteromonas sp1A1 do 
not inhibit the activity of E. coli LPS (Figure 27 b). In conclusion, 
Pseudoalteromonas sp1A1 LPS do not possess any agonist or antagonist 
properties toward the mammal immune system. 
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Figure 27: Immunological assays with Pseudoalteromonas sp 1A1 LPSs. (A) 
Measurement of TNF production by ELISA with THP1 human cell line and (B) 
measurement of SEAP absorbance by Quanti-blue assay with Raw-Blue-hTLR4 murine 
cell line. Cells were incubated with the indicated amounts of Pseudoalteromonas sp1A1 
and E. coli 0111:B4 LPS. Error bars represent the standard deviation of the mean of 
biological triplicates. Graph is representative of at least three independent experiments 
 
3.7. Conclusion 
 
This chapter reports the full structural characterization of 
Pseudoalteromonas sp. 1A1 LPS. Its O-antigen is composed of a branched 
repeating unit that includes specific features as the presence of KDN and 
the linkage with a pyruvate. Its core oligosaccharide is composed of a 
phosphorylated pentasaccharides, with heptose and Kdo residues linked to 
the lipid A. Finally, Pseudoalteromonas sp1A1 possesses a mixture of Lipid 
A species, bis-phosphorylated and differently acylated, the penta-acylated 
with a 3+2 symmetry. It is also interesting to note that Pseudoalteromonas 
sp1A1 actually possesses the same Lipid A mixture as Pseudoalteromonas 
sp2A71. Indeed, Pseudoalteromonas sp1A1 is a pathogenic bacterium for S. 
domoncula and Pseudoalteromonas sp2A is an opportunistic bacterium. 
This different properties, despite the similar structure, can be explained by 
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the fact that Pseudoalteromonas sp1A1 does not influence sponge TLR-
related pathway, contrary to E. coli Lipid A66. The activation of S. 
domoncula immunity may be triggered by other PRR/PAMP interactions. 
Concerning the immunostimulant activity in human and mice, this 
study revealed no significant agonist or antagonist properties of 
Pseudoalteromonas sp1A1 LPS that have hence no significant interaction 
with TLR4/MD-2 signaling either in mammals or with sponges in its natural 
environment. 
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Chapter 4: In silico study of the outer-
membrane of Pseudoalteromonas sp1A1 
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4.1. Molecular dynamic simulation of Gram-negative 
bacteria OM 
 
 The envelope of Gram-negative bacteria (Outer Membrane, OM) is a 
complex structure (See Section I), and the elucidation of its properties is 
important in order to gain insight about its interaction with its environment. 
In this context, Molecular Dynamic Simulations (MDS) of Gram-negative 
cell envelope have increasingly been performed during the last decade. 
The first designed asymmetric OM was from Pseudomonas aeruginosa 
PA0174. Other MDS of Gram-negative cell envelope lead to a better 
understanding of its structure and dynamics. This knowledge is a useful tool 
for the development of antibiotics and the prediction of new compounds for 
immunotherapy75. Investigations done with of E. coli OM showed the 
importance of the presence of LPS in the OM simulations. Indeed, LPS are 
involved in several membrane properties as its permeability and its 
interaction with OMPs76.  
It is now known that the LPS composition of an OM influence its 
overall properties. Indeed, a coarse-grain model of an asymmetric 
membrane showed that the presence of LPS is related to a diminution of 
the membrane melting point and an increase of its area per lipids77. Another 
study was performed with several homogeneous LPS bilayer at atomic level 
and highlighted several point as:  (i) the area per lipid of a membrane is 
correlated to the number of acyl chains of its LPS and (ii) its hydrophobic 
thickness is linked with the length of the acyl chains78. 
 In this context, the present chapter reports in silico study of 
Pseudoalteromonas sp1A1 OM at atomic level. The experiments were 
designed in order to see if the OM was influenced by the Lipid A structure 
previously characterized (See Section II). Additionally, the properties of the 
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LOS itself were studied in order to understand if the presence of salts can 
modulate its structural conformation. 
 
4.2. Molecular dynamic simulation of 
Pseudoalteromonas sp1A1 OM 
 
In order to understand Pseudoalteromonas sp1A1 Outer-Membrane 
(OM) behaviour, several systems were built in silico. Three kind of bilayers 
were studied (i) an homogeneous POPE:POPG (3:1) bilayer (Figure 28), 
similar to the inner membrane of Gram-Negative bacteria79, (ii) the same 
system with a single inserted Lipid A and (iii) an asymmetric lipid A 
containing bilayer. The goal was to determine if the properties of the OM 
could be influenced by the presence of a Lipid A.  
 
 
Figure 28: Structure of Palmitoyloleoyl Phosphatidylglycerol (POPG) and 
Palmitoyloleoyl Phosphatidylethanolamine (POPE) 
   
56 
 
To do so, a POPE:POPG (3:1) bilayer containing 128 lipids was 
generated using CHARMM-GUI80 (Figure 29 A). Molecular dynamic 
simulation of this membrane was performed during 100 ns using AMBER 
Lipid1181 and Lipid1482 force fields. After the simulation, its hydrophobic 
thickness and area per lipid were calculated using CPPTRAJ software83, 
giving the properties of a homogeneous bilayer. Meanwhile, 
Pseudoalteromonas sp1A1 Lipid A was built calculating electrostatic 
charges of each of its residues (Figure 29 B). This study was focused on 
the main Lipid A species with homogeneous C12:0(3-OH) acylation (See 
Figure 24). This molecule was built with negatively charged phosphate 
groups and inserted in an octahedral TIP3P water box. Then molecular 
dynamic simulation was done for 100 ns, allowing the fatty acid chains to 
gather due to the hydrophobic effect (Figure 29 C). Then, using PyMOL 
software, a single Lipid A was inserted in the previous POPE:POPG bilayer 
(Figure 29 D). Another molecular dynamic simulation was performed during 
100 ns and hydrophobic thickness and area per lipid were once again 
calculated, giving the properties of bilayer with a single inserted Lipid A.  
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Figure 29: Snapshot from the molecular dynamic simulation of a single Lipid A from 
Pseudoalteromonas sp1A1 in a POPE:POPG (3:1) bilayer. A: POPE:POPG (3:1) bilayer 
built with CHARMM-GUI. B: Pseudoalteromonas sp1A1 Lipid A. C: Pseudoalteromonas 
sp1A1 Lipid A after 100ns of MDS in explicit water. D: Pseudoalteromonas sp1A1 Lipid A 
inserted in POPE:POPG (3:1) bilayer 
 
Finally, to better mimic the real OM of gram-negative bacteria, an 
asymmetric bilayer was studied. The inner leaflet was composed of 
POPE:POPG (3:1) and the outer leaflet of 75% of Lipid A and 25% of 
POPE:POPG (3:1). Both leaflets were generated separately. The inner 
leaflet was created from of a 168 POPE:POPG (3:1) bilayer generated with 
CHARMM-GUI. The outer leaflet was generated manually. Firstly, the Lipid 
A was extracted after its MDS in POPE:POPG (3:1) bilayer (Figure 29 D). 
Then it was duplicated until a 30 Lipid A grid was obtained (Figure 30 A). 
Using PYMOL, the Lipid As were reorganized in order to leave place for 
other lipids (Figure 30 B). Then 8 POPE and 2 POPG were added (Figure 
30 C). The obtained Lipid A / POPE:POPG proportions are consistent with 
the ones used in previous studies77.   
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Figure 30: Top-view snapshot of the generation of Pseudoalteromonas sp1A1 outer 
leaflet. A: generation of a 30 Lipid A grid; B: re-organisation of the grid; C: insertion of 8 
POPE and 2 POPG 
 
Finally, both inner and outer leaflet were combined using PyMOL 
(Figure 31 A). Molecular dynamic simulation of this new system was 
performed for 100ns. During the simulation, the membrane equilibrated 
reaching a stable conformation (Figure 31 B) and area per lipid and 
electron density were calculated. Some differences could be observed 
during the comparison of the properties of the 3 different membranes 
(bilayer without Lipid A, bilayer with single Lipid A and asymmetric bilayer, 
Figures 29 A, 29 D, and 31 B). Although the hydrophobic thickness was 
constant, the area per lipid of the asymmetric membrane was lower than 
the ones of the other bilayers. The electron density always showed a 
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hydrophobic thickness of 40 Å (Figure 32, C-D) but an asymmetric profile 
could be clearly seen with the third membrane (Figure 32 D). Moreover, the 
area per lipid stabilised around 52 Å2 for homogeneous bilayers (Figure 32 
A) and fluctuated around 67 Å2 for the asymmetric membrane (Figure 32 
B). Such system give Pseudoalteromonas sp1A1 OM a higher flexibility. 
 
Figure 31: Assymetric bilayer before (A) and after (B) MDS for 100ns. Inner leaflet is 
composed of POPE:POPG (3:1) and Outer Leaflet is composed of 75% Lipid A and 25% 
POPE:POPG (3:1) 
 
 
Figure 32: Area per lipids and electron density of POPE:POPG (3:1) bilayer with single-
inserted Lipid A (A,C) and asymmetric bilayer (B,D) 
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Finally, dihedral angles of the glucosamine backbone from 
Pseudoalteromonas sp 1A1 Lipid A were calculated after each simulations 
(Figure 33). No difference was detected compared to the free lipid A. The 
insertion of the molecule in a membrane do not influence its conformation. 
 
 
 
Figure 33: Conformational angles of the di-glucosamine backbone of Pseudoalteromonas 
sp1A1 Lipid A (1) in water and (2) inserted in POPE:POPG (3:1) bilayer 
 
 
4.3. Molecular dynamic simulation of 
Pseudoalteromonas sp1A1 LOS 
 
Another set of experiment was performed with Pseudoalteromonas 
sp1A1 LOS (See Figure 26). The goal was to study its oligosaccharide 
conformation in different environments. The oligosaccharide from 
Pseudoalteromonas sp1A1 was generated with GLYCAM and then inserted 
on the previously studied Lipid A (Figure 34). 
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Figure 34: Snapshot of the oligosaccharide (A) and LOS (B) from Pseudoalteromonas 
after 100ns MDS in explicit water 
 
Molecular dynamic simulation were performed during 50 ns in explicit 
water and 0.5 M of NaCl, that is closed to the salt concentration of its 
natural marine habitat. After simulations, dihedral angles between each 
monosaccharides were calculated and compared. Interesting feature was 
observed for the ω torsional angle between the Kdo from the core 
oligosaccharide and its linked glucosamine from the Lipid A. Indeed, during 
the simulation this angle was rotating between two values (Figure 35), one 
positive angle around 50° and another negative angle around -50°. When 
the LOS was in water, the positive value was preponderant but in salt the 
negative one predominated. This shows that salty environment have an 
influence on LOS conformation. 
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Figure 35: Omega tortional angle between the Kdo and reducing glucosamine of the LOS 
from Pseudoalteromonas sp1A1 
 
 
4.4. Discussion  
 
Molecular dynamic simulation allowed a better understanding of 
Pseudoalteromonas sp1A1 properties. The influence of the Lipid A 
repartition was investigated. It was found that asymmetric membrane with 
75% of Lipid A on one of their leaflet had higher area per lipid (67 Å2) than 
homogeneous POPE:POPG (3:1) membranes (52 Å2). Such repartition of 
Lipid A confer a higher flexibility to the OM. Those data are consistent with 
previous study with other membranes. Indeed, a coarse-grain model of LPS 
enriched OM also found an area per lipid of 0.67 nm2 for a membrane 
containing 70% of LPS and 0.55 nm2 for a membrane containing 10% of 
LPS77. The presented results are hence another confirmation that the 
presence of LPS indeed influence the membranes properties. 
This study also showed that the presence of salt in the environment 
could influence the conformation of the oligosaccharide and in particular the 
linkage between GlcN from the Lipid A and Kdo from the core 
oligosaccharide. This could be due to the interaction between Na+ cations 
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and the negatively charged phosphate groups present on those sugars. 
This work was made in collaboration with Prof. Martin-Santamaria at CSIC 
in Madrid, Spain, whose team is currently making further investigation.  
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Section III 
Structure and activity of Lipid A 
from halophiles 
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Chapter 5: Stucture of the Lipid A from 
Spiribacter salinus M19-40T 
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5.1. Halophilic micro-organisms  
 
 Halophiles are extremophiles that can live in hypersaline 
environment (See Section I, 1.5.1.). Halophilic bacteria comprise various 
species that can be found in diverse habitat, as salt lakes, saltern pounds 
and deep sea brines84. Halophiles developed two main strategy in order to 
survive in high salt concentration. In the “salt-in” strategy, halophiles 
produce proteins with a high proportion of negatively charged amino 
acids85. Such metabolites allow them to balance their osmotic pressure by 
accumulating Na+ and K+ counter-ions in their cytoplasm. The other 
strategy, called the “salt-out” strategy, consist in the production and 
accumulation of large amount of organic solutes in order to maintain the 
osmotic balance. The osmolytes are highly diverse and can be used for 
industrial applications86. Indeed, halophiles are appealing microorganisms 
for biotechnology. They are currently studied for their ability to produce 
metabolites with particular properties. For example, their protease can 
function in low-water environment and tolerate organic solvent87. They also 
produce other enzymes, as amylase, chitinase and lipase, and 
exopolysaccharides that can have practical applications88. 
Recent metagenomics analysis of hypersaline environment allowed 
the isolation and characterization of new halophiles genus and species89. It 
is the case of Spiribacter spp. that now comprise several organisms as 
Spiribacter curvatus90 and Spiribacter roseus91. Spiribacter salinus M19-40T 
is the first isolated species of this genus. It is a halophilic Gram-negative 
gamma-proteobacterium identified as a new genus based on 
metagenomics analysis with close phylogenetic similarities with species of 
the genera Alkalilimnicola, Alkalispirillum and Arhodomonas within the 
family Ectothiorhodospiraceae92. It has been firstly isolated from an 
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intermediate-salinity pound of a marine saltern located in Isla Cristina, 
Huelva, southwest Spain. It is now known that S. salinus M19-40T adapts to 
its environment with the “salt-out” strategy, producing osmolytes as ectoine 
and glycine betaine93. 
As a gram-negative bacterium, S. salinus M19-40T produce LPS that 
can have interesting structure and properties (See Section I). The present 
chapter reports the structural characterization of S. salinus M19-40T Lipid A. 
This is achieved by merging information that was attained from the 
compositional analyses performed on pure LPS with information from a 
MALDI MS and MS2 investigation executed on the isolated lipid A fraction. 
 
5.2. Extraction, purification and compositional 
analysis  
 
LPS material was extracted from dried bacterial cells using the hot 
phenol/water procedure. The LPS material was found only in the water 
phase and underwent an enzymatic treatment in order to remove cell 
contaminants. A DOC-PAGE, followed by silver nitrate staining, was 
performed, revealing the rough nature (R-LPS) of the extracted material. An 
additional purification step was performed by ultracentrifugation, followed 
by size-exclusion chromatography. The compositional analysis executed on 
R-LPS revealed that S. salinus M19-40T lipid A was mainly composed of 
(R)-3-hydroxydecanoic acid (10:0 (3-OH)), (R)-3 hydroxytetradecanonic 
acid (14:0 (3-OH)), 3-oxo-tetradecanonic acid (14:0 (3-oxo)), and 
dodecanoic acid (12:0). Decanoic (10:0), undecanoic (11:0), tridecanoic 
(13:0), tetradecanoic (14:0), and tetradecenoic (14:1) acids were also 
detected as minor species.  
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The presence of the 14:0 (3-oxo) fatty acid was confirmed by the 
analysis of the fragmentation pattern of its methyl ester derivative (Figure 
36) as it follows: (i) the presence of the molecule-ion peak at m/z 256 and 
(ii) the presence of the base peak at m/z 116, which clearly proved the beta 
cleavage to the oxo group with rearrangement of one hydrogen atom94. 
Moreover, (iii) the minor peak at m/z 183 [M-73]+, which was indicative of 
the alpha cleavage to the oxo group, was also identified95. The occurrence 
of the 14:0 (3-oxo) fatty acid could not be shown using the typical 
procedure to define the total fatty acid, most likely because of 
decarboxylation. On the contrary, liberation of fatty acids by methanolysis 
with methanol/hydrochloric acid revealed the occurrence of 14:0 (3-oxo). 
 
Figure 36: Mass spectrum of the methyl 3-oxotetradecanoic acid ester 
 
5.2. Mass spectrometry of the Lipid A 
 
An aliquot of pure R-LPS underwent a mild acid hydrolysis with an 
acetate buffer in order to selectively cleave the acid labile linkage between 
the core oligosaccharide and the lipid A. The isolated lipid A fraction then 
underwent a detailed MALDI MS and MS2 investigation. The reflectron 
MALDI mass spectrum, which was recorded in negative polarity, is 
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presented in Figure 37. The spectrum clearly indicated—in the range m/z 
1039.6–1499.9—a complex pattern of peaks relative to deprotonated [M-H]- 
lipid A species, which differed in both the nature and number of fatty acids 
and in phosphate content. Three main clusters of peaks were detected and 
matched with penta-, tetra-, and tri-acylated lipid A species, whose 
heterogeneous nature was also clearly visible because of the presence of 
mass differences of 14 (–CH2– unit) and/or 28 amu (–CH2CH2– unit), which 
are diagnostic for lipid A species that differ in the length of their acyl chains, 
in accordance with compositional analysis data. In detail, the cluster of 
peaks at approximately m/z 1391.9 and m/z 1471.9 were assignable to 
mono- and bis-phosphorylated penta-acylated lipid A species (Figure 37, 
Table 3) carrying two 10:0 (3-OH), one C14:0 (3-OH), one C14:0 (3-oxo), 
and one C12:0. In the mass range m/z 1193.8-1301.7, tetra-acylated lipid A 
species were identified: the peak at m/z 1301.7 matched with bis-
phosphorylated tetra-acylated lipid A species carrying one 10:0 (3-OH), one 
14:0 (3-OH), one 14:0 (3-oxo), and one 12:0. The corresponding mono-
phosphorylated form was assignable to the peak at m/z 1221.8. In the 
same mass range, mono-phosphorylated lipid A species that differed in the 
length of the acyl chains were clearly visible because of the occurrence of 
mass differences of 14 and 28 amu, as stated above. Finally, mono-
phosphorylated tri-acylated lipid A species that were lacking in both 10:0 (3-
OH) and 12:0, with respect to the penta-acylated lipid A species at m/z 
1391.9, were also visible at m/z 1039.6 (Figure 37, Table 3). 
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Figure 37: Reflectron MALDI mass spectrum, recorded in negative polarity, of lipid A from 
S. salinus M19-40T LPS obtained after acetate buffer treatment. Only deprotonated ions 
[M-H]- are formed in these conditions. The lipid A species are indicated. 
 
 
Table 3: Proposed interpretation of main peak ions of MALDI-TOF MS (Figure 37) 
 
To define the detailed structure of S. salinus M19-40T lipid A, 
unveiling the location of the acyl moieties with respect to the glucosamine 
disaccharide backbone, an MS2 analysis on several peaks was performed. 
In detail, the negative-ion MS2 spectrum of the precursor ion at m/z 1391.9 
(Figure 38), corresponding to a mono-phosphorylated penta-acylated lipid A 
species, showed an intense peak at m/z 1203.7. This was attributed to an 
ion derived from the loss of a 10:0 (3-OH) fatty acid. A less intense peak 
was also observed at m/z 1191.7 and was assigned to a fragment that 
Observed ion 
peak (m/z) 
Acyl 
Substitution Proposed Fatty acid/phosphate composition 
1471.9 Penta-acyl HexN2P[C10:0 (3-OH)]2 [C12:0] [C14:0 (3-OH)] [C14:0 (3-oxo)] 
1391.9 Penta-acyl HexN2[C10:0 (3-OH)]2 [C12:0] [C14:0 (3-OH)] [C14:0 (3-oxo)] 
1301.7 Tetra-acyl HexN2P[C10:0 (3-OH)] [C12:0] [C14:0 (3-OH)] [C14:0 (3-oxo)] 
1221.8 Tetra-acyl HexN2[C10:0 (3-OH)] [C12:0] [C14:0 (3-OH)] [C14:0 (3-oxo)] 
1039.6 Tetra-acyl HexN2[C10:0 (3-OH)] [C14:0 (3-OH)] [C14:0 (3-oxo)] 
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originated from the loss of one 12:0 unit. Further minor peaks at m/z 1003.5 
and m/z 1015.6 were identified and assigned as follows: (i) the ion at m/z 
1003.5 matched with a fragment originated from the sequential loss of one 
10:0 (3-OH) and one 12:0 unit, whereas (ii) the ion at m/z 1015.6 
corresponded to a lipid A piece lacking two 10:0 (3-OH) moieties. The 
observation of both of these fragmentations was fundamental for the 
structural characterization. Indeed, the presence of a fragment that 
originated from a sequential loss of 10:0 (3-OH) and 12:0 from the 
precursor ion—in addition to the absence of fragmentations that referred to 
the loss of a whole unit of a hydroxylated fatty acid bearing a secondary 
acyl substituent — concurred to indicate that the secondary 12:0 was 
bound to an N-linked primary fatty acid. Moreover, the occurrence of the ion 
at m/z 694.1, originating from the sugar ring fragmentation (0,4A2), was 
crucial to establish the nature of the primary fatty acids that decorated the 
non-reducing glucosamine unit (that is, one 10:0 (3-OH) and one 14:0 (3-
oxo)), and thus to locate the secondary acyl chain 12:0 only at the reducing 
glucosamine unit. 
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Figure 38:  MALDI MS/MS spectrum of the mono-phosphorylated penta-acylated lipid A 
species at m/z 1391.8 from S. salinus M19-40T LPS. Fragment assignments are reported. 
The proposed structure for the penta-acylated lipid A species is reported in the inset. 
 
The MS2 analysis of the precursor ion at m/z 1221.8 (Figure 39), 
corresponding to a tetra-acylated and mono-phosphorylated species, 
indicated an intense peak at m/z 1021.6, which was attributed to an ion 
derived from the loss of the 12:0 moiety. A subsequent rearrangement of 
the ion at m/z 1021.6, promoted by the free 3-OH group on the 14:0, gave a 
loss of 184 mass units (C12H24O), resulting in the ion at m/z 837.4 (Figure 
39)96. This fragmentation was helpful to establish that the primary 14:0 (3-
OH) was sitting at position 2 of the reducing glucosamine. Moreover, the 
observation of such fragmentation, which occurred only when the 
secondary 12:0 unit was absent, suggested that the latter could be linked to 
the 14:0 (3-OH) moiety. A further intense peak, at m/z 923.4, was assigned 
to a fragment devoid of both the 12:0 unit and the phosphate group. A 
minor peak was also observed at m/z 1033.6, matching with a fragment that 
originated from the loss of a 10:0 (3-OH) acyl moiety (Figure 39). Two ions, 
derived from sugar ring fragmentations 0,4A2 (m/z 694.3) and 1,3A2 (m/z 
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754.1), were also detected. In particular, cross-ring fragmentation 1,3A2 (m/z 
754.1), which only took place when the hydroxyl group at position 3 of the 
reducing glucosamine was not substituted, further confirmed that the 
missing 10:0 (3-OH) acyl chain was placed in that position, and thus that 
14:0 (3-OH) and 12:0 were located at position 2 of the same glucosamine 
as the primary and secondary fatty acids, respectively. 
 
Figure 39: MALDI MS/MS spectrum of the mono-phosphorylated tetra-acylated lipid A 
species at m/z 1221.8 from S. salinus M19-40T LPS. Fragment assignments are reported. 
The proposed structure for the tetra-acylated lipid A species is reported in the inset. 
 
The MS2 analysis of the precursor ion at m/z 1301.7 (Figure 40), 
relative to a bis-phosphorylated tetra-acylated lipid A species, confirmed the 
structural characterization. This was because the occurrence of both the Y1 
ion (m/z 666.3)—which originated from the cleavage of the glycosidic 
linkage of the glucosamine backbone—and the ring fragmentation-derived 
ion 1,3A2 (m/z 834.6) clearly indicated that the reducing glucosamine was 
decorated by 14:0 (3-OH) and 12:0, whereas the non-reducing glucosamine 
was acylated by 10:0 (3-OH) and 14:0 (3-oxo). Once again, the loss of 184 
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mass units was detected only from a fragment that was lacking in the 
secondary 12:0 unit. 
 
Figure 40: MALDI MS/MS spectrum of the bis-phosphorylated tetra-acylated lipid A 
species at m/z 1301.8 from S. salinus LPS. Fragment assignments are reported. The 
proposed structure for the tetra-acylated lipid A species is reported in the inset. 
 
The positive-ion MALDI MS spectrum confirmed the presence of the 
molecular mass of the lipid A species with Na+ counterions. A very 
diagnostic peak for structural elucidation was detected at m/z 636.3 (Figure 
41) and attributed to the oxonium ion. This important fragment ion arose 
from the cleavage of the glycosidic linkage and was indicative of the 
substitution on the non-reducing glucosamine unit, which confirmed that it 
bore one 14:0 (3-oxo) and one 10:0 (3-OH). Finally, a further peak at m/z 
466.2 was identified and assigned to the oxonium ion that was lacking the 
10:0 (3-OH) unit (Figure 41). 
 
1,3A2
Y1
Precursor ion m/z 1301.7 
654.0 765.6 877.2 988.8 1100.4 1212.0 
Mass (m/z) 
0
10
20
30
40
50
60
70
80
90
100 
%
 In
te
ns
ity
In
te
ns
ity
 
 
1090.5 
736.7666.3 
834.6
917.7 
817.6
1003.8 
1203.8 
H3PO4 
1113.7
1101.7 
-10:0 (OH) 
-12:0 
-12:0 
-H3PO4 -12:0 -184 
1,3A2 
H3PO4 
Y1 
   
75 
 
 
Figure 41: Section of the reflectron MALDI mass spectrum, recorded in positive polarity, of 
lipid A from S. salinus M19-40T LPS obtained after acetate buffer treatment. The oxonium 
ion structure is also sketched. 
 
Finally, in order to unambiguously define the composition and 
position of the secondary fatty acids, an aliquot of lipid A underwent an 
ammonium hydroxide hydrolysis. The negative-ion MALDI mass spectrum 
(Figure 42) of the ammonium-treated lipid A displayed the following peaks 
that were important for the structural assessment, particularly in the mass 
range m/z 869.1–1051.2: (i) the ion at m/z 1051.2, which was explained as 
a mono-phosphorylated tri-acyl residue that was composed of both the 
primary N-linked 14:0 (3-OH) and 14:0 (3-oxo), with the former carrying the 
secondary 12:0 unit, and (ii) the ion at m/z 869.1, which was attributed to 
the mono-phosphorylated di-acyl residue that was composed only of the N-
linked primary acyl moieties 14:0 (3-OH) and 14:0 (3-oxo). The occurrence 
of both of these peaks further corroborated the nature of the amide-bound 
acyl moieties and the occurrence of 12:0 as a secondary fatty acid in an 
acyloxyacyl amide moiety. 
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Figure 42: Negative ion MALDI mass spectrum of the lipid A from S. salinus M19-40T LPS 
obtained from 10 % NH4OH hydrolysis. The proposed structures of the product are 
reported in the figure. 
 
Thus, through a combination of analytical organic chemistry, and the 
merging of MS and MS2 data of the mild acid hydrolysis and the ammonium 
hydroxide-treated products with those from the compositional analysis, it 
was possible to define the S. salinus M19-40T LPS as expressing a 
complex blend of the lipid A species—of which the component with the 
highest acylation degree is sketched in Figure 43. 
 
Figure 43: Structure of Spiribacter salinus M19-40T Lipid A 
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5.3. Discussion 
 
 The adaptation mechanisms of marine bacteria to the different 
chemical, physical, and biological conditions that are encountered in marine 
environments have led to the evolution of highly diverse microbes. The 
adaptation phenomena typically involve the chemical modification of the 
bacterial membrane system in order to reinforce the overall cell envelope to 
resist the mutable conditions of the saline habitats. The structure of the LPS 
from halophilic microbes often presents unusual chemical characteristics, 
which help the bacterium in maintaining membrane integrity. In particular, 
the nature and distribution of the fatty acids composing the lipid A moiety 
may change according to the external habitat. In this paper, the 
characterization of the structure of the lipid A moiety of the R-LPS that was 
isolated from the slightly halophilic bacterium S. salinus M19-40T is 
reported. The structural elucidation was performed, through MALDI MS and 
MS2 analysis, on the isolated lipid A. In parallel, a detailed fatty acid 
compositional analysis was executed on the LPS, providing the chemical 
constituents of the lipid A, which are essential to interpret the information 
derived from the MALDI MS investigation. 
S. salinus M19-40T appeared to possess an R-LPS with a 
heterogenous lipid A, characterized by a mixture of tri-, tetra-, and penta-
acylated species, and decorated by one or two phosphate groups. In 
general, the 14:0 (3-OH) fatty acid was always found to be acyloxyamide 
linked to the reducing glucosamine; whereas 14:0 (3-oxo) was always 
found to be acyloxyamide decorating the non-reducing glucosamine; 
position 3 and 30 were substituted with 10:0 (3-OH); and finally, the 12:0 
unit was identified as a secondary substituent only of the reducing 
glucosamine. As indicated in Figure 43, the main penta-acylated lipid A 
   
78 
 
species exhibits a 2 + 3 symmetry. Such an uncommon fatty acid 
distribution is interesting as most of the penta-acylated lipid A species—
whose structure has been characterized to date—show a 3 + 2 asymmetry.  
The unusual distribution of acyl substituents over the backbone 
resembles that of the lipid A of two psychrophilic and moderately halophilic 
bacteria, namely Marinomonas vaga97 and Marinomonas communis98, even 
though the chain length of the fatty acids is different. Moreover, M. vaga 
and M. communis possess only mono-phosphorylated species, and their 2 
+ 3 asymmetry is given by both the occurrence of a secondary acyl 
substitution on the acyloxyamide of the non-reducing glucosamine and by 
the absence of the primary ester-bound fatty acid decorating the same 
glucosamine unit. 
Even more interestingly, S. salinus M19-40T lipid A presented the 
rare amide-linked 14:0 (3-oxo), whose presence is consistent with the close 
phylogenetic similarities with species within the family 
Ectothiorhodospiraceae. Indeed, previous studies revealed that the LPS 
isolated from the extremely halophilic Ectothiorhodospira halophila also 
expresses the amide-bound 14:0 (3-oxo) fatty acids. Moreover, similarities 
with other Ectothiorhodospira species in lipid A fatty acid composition have 
been highlighted99. 
Given that, depending on the nature and distribution of the acyl 
chains, the lipid A may induce a TLR4/MD-2 agonistic or antagonistic 
activity after interaction with the host immune cells’ receptors, it is worth 
emphasizing that the presence of the 3-oxo fatty acids has also been 
shown for lipid As from Rhodobacter sphaeroides and R. capsulatus, two 
phototrophic bacteria that are of enormous importance in the LPS research 
field. Indeed, these bacteria exhibited a penta-acylated lipid A with strong 
TLR4/MD-2 antagonistic activity against toxic LPS and were used as an 
inspiration model for synthesis of the analogue Eritoran: a well-tolerated, 
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synthetic lipid A mimetic, acting as a TLR4/MD-2 antagonist, which reached 
phase III clinical trials as an antisepsis agent100. 
Therefore, given the peculiar elucidated structure, the immunological 
activity of the lipid A from S. salinus M19-40T LPS is also worth being 
investigated, since it can potentially provide interesting activities in the 
perspective of the development of analogues with an immunomodulatory 
action on the immune system. 
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Chapter 6: Stucture and activity of the 
Lipid A from Halopeptonella vilamensis 
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Halopeptonella vilamensis is a halophilic Gram-negative gamma-
proteobacterium isolated from a hypersaline lake, Laguna Vilama, in 
Argentina101. It was identified as a new genus and species that have 
phylogenetic similarities with species of the genera Alkalilimnicola, 
Alkalispirillum, Arhodomonas and Spiribacter within the family 
Ectothiorhodospiraceae. Halopeptonella vilamensis is the first, and at 
present time, only member of the Halopeptonella genus. 
 
 6.1. Extraction, purification and compositional 
analysis  
 
Extraction of the LPS content was done using the hot phenol/water 
procedure. LPS material was only found in the water phase and was further 
purified by enzymatic treatment, in order to remove cell contaminants as 
nucleic acids and proteins. A DOC-PAGE with subsequent silver nitrate 
staining was carried out. It showed that the extracted material was a LOS, 
with a characteristic single band at the bottom of the gel (Figure 44). It was 
further purified using size-exclusion chromatography. 
 
Figure 44: DOC-PAGE; A: LOS from Halopeptonella vilamensis, water phase; B; LPS 
from E. coli standard 
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The compositional analysis of purified LOS from H. vilamensis 
revealed that its oligosaccharide was composed of D-Glucuronic acid (D-
GlcA), D-Mannose (D-Man), D-Galactose (D-Gal), D-Glucose (D-Glc), D-
Galacturonic acid (D-GalNA), D-Glucosamine (D-GlcN) and Kdo. Its Lipid A 
was composed of (R)-3-hydroxydecanoic acid (C10:0 (3-OH)), (R)-3-
hydroxydecenoic acid (C10:1 (3-OH)), dodecanoic acid (C12:0), 
dodecenoic acid (C12:1), (R)-3-hydroxydodecanoic acid (C12:0 (3-OH)), 
tridecanoic acid (C13:0), tetradecanoic acid (C14:0) and tetradecenoic acid 
(C14:1). This heterogeneous mixture of fatty acids is shown in Figure 45. 
 
 
Figure 45: GC-MS chromatogram of methyl-ester derivates of fatty acids from H. 
vilamensis 
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6.2. Mass spectrometry of the Lipid A 
 
The Lipid A was isolated from the pellet of the mild acid hydrolysis 
performed on the LOS. It was then studied by MALDI MS and MS2 analysis. 
The reflectron negative-ion MALDI MS is represented in Figure 46. A 
complex pattern of ion peaks [M-H]- was detected in the mass range m/z 
[997.6-1597.9]. Four clusters of peaks were detected, corresponding to 
hexa, penta, tetra and tri-acylated Lipid A species (Figure 46, Table 4). The 
occurrence of mass difference of 14 (-CH2-unit) and 28 amu (-CH2-CH2-
unit) showed that H. vilamensis possesses a highly heterogeneous mixture 
of Lipid As, differing by the length of their fatty acids. Differences of 2 amu 
were also observed within the clusters, showing that there is a mixture of 
species bearing saturated and unsaturated acyl chains. This heterogeneity 
was also detected in the previous compositional analysis (Figure 46). 
 
 
 
 
 
 
 
 
 
 
 
Figure 46: Reflectron MALDI mass spectrum, recorded in negative polarity, of lipid A from 
H. vilamensis LPS obtained after acetate buffer treatment. Only deprotonated ions [M-H]- 
are formed in these conditions. The lipid A species are indicated. 
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In detail, the set of peaks at m/z 1597.9 and 1519.0 matched with 
bis- and mono-phosphorylated hexa-acylated species carrying two C10:0 
(3-OH), two C12:0 (3-OH), one C12:0 and one C12:1. The bis- and mono- 
phosphorylated penta-acylated species lacking one C10:0 (3-OH) were 
respectively detected at m/z 1427.8 and 1347.8. Clusters at m/z 1257.7 and 
1177.7 corresponded to bis- and mono-phosphorylated tetra-acylated 
species lacking two C10:0 (3-OH). Finally, sets of peaks at m/z 1077.5 and 
977.6 matched with bis- and mono-phosphorylated tri-acylated species 
bearing two C12:0 (3-OH) and one C12:0 (Figure 46, Table 4). 
 
Observed ion 
peak (m/z) 
Acyl 
Substitution Proposed Fatty acid/phosphate composition 
1597.9 Hexa-acyl HexN2P2 [C10:0 (3-OH)]2 [C12:0 (3-OH)] 2 [C12:0] [C12:1] 
1519.9 Hexa-acyl HexN2P [C10:0 (3-OH)]2 [C12:0 (3-OH)] 2 [C12:0] [C12:1] 
1427.8 Penta-acyl HexN2P2 [C10:0 (3-OH)] [C12:0 (3-OH)] 2 [C12:0] [C12:1] 
1347.8 Penta-acyl HexN2P [C10:0 (3-OH)] [C12:0 (3-OH)] 2 [C12:0] [C12:1] 
1257.7 Tetra-acyl HexN2P2 [C12:0 (3-OH)] 2 [C12:0] [C12:1] 
1247.7 Tetra-acyl HexN2P2 [C10:0 (3-OH)]2[C12:0 (3-OH)] 2 [C12:0]  
1177.7 Tetra-acyl HexN2P[C12:0 (3-OH)] 2 [C12:0] [C12:1] 
1077.5 Tri-acyl HexN2P2 [C12:0 (3-OH)] 2 [C12:0]  
997.6 Tri-acyl HexN2P [C12:0 (3-OH)] 2 [C12:0]  
Table 4: Proposed interpretation of main peak ions of MALDI-TOF MS (Figure 46) 
 
In order to determine to position of the acyl moieties regarding the di-
glucosamine backbone, several MS2 analysis were carried out. The MS2 
spectrum of the precursor ion at m/z 1177.7 is shown in Figure 47. The 
analysed species matched with a mono-phosphorylated tetra-acylated Lipid 
A containing two C12:0 (3-OH), one C12:0 and one C12:1 (table 4). Ion 
peak at m/z 1077.6 matched with the loss of a phosphate group. Clusters at 
m/z 977.4 and 799.1 corresponded to the lipid A lacking respectively one 
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C12:0 and one C12:0 (3-OH). More interestingly, an ion peak from the 1,3A2 
ring fragmentation could be observed at m/z 738.2. It showed that the non-
reducing unit was composed of one C12:0 (3-OH) and one C12:1.  
 
 
 
 
 
 
 
Figure 47: MALDI MS/MS spectrum of the mono-phosphorylated tetra-acylated lipid A 
species at m/z 1177.7 from H. vilamensis LOS. Fragment assignments are reported. The 
proposed structure for the tetra-acylated lipid A species is reported in the inset. 
 
This analysis was confirmed by another MS2 analysis done on the 
precursor ion m/z 1258.7 that corresponded to the bis-phosphorylated tetra-
acylated species bearing two C12:0 (3-OH), one C12:0 and one C12:1 
(Figure 48). The most abundant ion peak at 1160.1 matched with a loss of 
a phosphate group. Cluster at 1059.9 corresponded to the loss of a C12:0, 
with a further loss of phosphate at m/z 963.8. Finally, the 1,3A2 ring 
fragmentation was visible at m/z 818.5 with a loss of a phosphate group at 
m/z 720.6. The ring cleavage Y1 was also detected at m/z 638.1. Those 
specific fragmentations confirmed the determined repartition of the acyl 
moieties along the di-glucosamine backbone. Each unit is composed of one 
C10:0 (3-OH) and one C12:0 (3-OH), C12:1 is anchored on the non-
reducing glucosamine whereas C12:0 is on the reducing unit. 
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Figure 48: MALDI MS/MS spectrum of the mono-phosphorylated tetra-acylated lipid A 
species at m/z 1258.7 from H. vilamensis LOS. Fragment assignments are reported. The 
proposed structure for the tetra-acylated lipid A species is reported in the inset. 
 
 Finally, other MS2 analysis showed consistent data. Indeed, the 
experiment performed on the precursor ion at m/z 1347.8 lead to the same 
conclusion about the structure of H. vilamensis Lipid A (Figure 49). The 
studied species corresponded to the mono-phosphorylated and penta-
acylated Lipid A carrying one C10:0 (3-OH), two C12:0 (3-OH), one C12:0 
and one C12:1. Peaks arising from the loss of phosphate groups were 
detected at m/z 1245.1 and the loss of C10:0 (3-OH) and C12:0 could 
respectively be seen at m/z 1159.8 and m/z 1147.5. 1,3A2 and Y1 
fragmentations were also detected at m/z 908.2 and m/z 556.0. They 
showed that the reducing glucosamine was bearing the C12:0 and C12:0 
(3-OH) and all the other acyl chains were on the non-reducing unit. Those 
data corroborate the previously defined repartition of the acyl chains among 
the di-glucosamine backbone. 
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Figure 49: MALDI MS/MS spectrum of the mono-phosphorylated Penta-acylated lipid A 
species at m/z 1347.8 from H. vilamensis LOS. Fragment assignments are reported. The 
proposed structure for the penta-acylated lipid A species is reported in the inset 
 
In order to precisely establish the nature of the ester or amide 
linkage, an aliquot of the Lipid A was treated with ammonium hydroxide 
hydrolysis. The negative ion MALDI MS (Figure 50) showed several cluster 
of peaks in the mass range m/z 1281.8-1059.6. As for previous MALDI MS 
(Figure 46), the heterogeneity of H. vilamensis Lipid A could be clearly seen 
with mass differences of 14 and 16 amu. The most abundant ion peak at 
m/z 1257.8 matched with bis-phosphorylated and tetra-acylated species 
lacking two C10:0 (3-OH). It confirmed that those two fatty acids are directly 
linked to the di-glucosamine backbone through ester linkages. Loss of 
phosphates could be observed at m/z 1177.6 and 1097.6. Finally, peaks at 
m/z 1077.7 and 1075.6 were crucial to determine the position of secondary 
fatty acids. Indeed, they correspond to bis-phosphorylated and tri-acylated 
species with two C12:0 (3-OH) and either one C12:0 or one C12:1. This 
clearly shows that the C12:0 (3-OH) are linked to the di-glucosamine 
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backbone through amide linkages, in turn esterified at the hydroxyl groups 
by C12:0 and C12:1. 
 
 
 
Figure 50: Negative ion MALDI mass spectrum of the lipid A from H. vilamensis LOS 
obtained from 10 % NH4OH hydrolysis. The proposed structures of the product are 
reported in the figure 
 
Combining all those data, it was possible to determine H. vilamensis 
Lipid A structures. It possesses a bis-phosphorylated hexa-acylated Lipid A 
with a 3+3 symmetry that is shown on Figure 51. The present analysis 
describe the data relative to the species bearing two C10:0 (3-OH) as 
primary ester-linked fatty acids, two C12:0 (3-OH) as amide-linked acyl 
chains, and one C12:0 and one C12:1 as secondary fatty acid. However, 
the high heterogeneity of MALDI mass spectra clearly demonstrated that H. 
vilamensis lipid A was characterised by a mixture of several species. The 
occurrence of 2 amu within each cluster (Figure 46) showed that H. 
vilamensis also possesses species with unsaturated acyl chains, as C12:1 
on the non-reducing unit or on both glucosamines. Finally, the 
compositional analysis (Figure 45) and the occurrence of 28 amu in the 
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negative-ion MALDI MS spectrum (Figure 46) also showed the presence of 
species bearing C14:0 and C14:1 instead of C12:0 and C12:1. 
 
Figure 51: Structure of Halopeptonella vilamensis hexa-acylated Lipid A species  
 
6.3. Immunological assays 
 
To evaluate the immunological impact of H. vilamensis LOS a first 
analysis was done at different concentrations (1, 10, and 100 ng/mL) in the 
HEK293 cell line102, stably transfected with human CD14/MD-2/TLR4. 
Similar concentration of the hexa-acylated, highly stimulatory LPS of E. coli 
O111:B4 and the synthetic lipid IVA were used as agonistic and 
antagonistic controls, respectively. Likewise, untreated cells were 
considered as the negative control in all the experiments shown. 
Stimulation of HEK293 hTLR4 was carried out for 6 h (Figure 52, A-B). It 
was observed that stimulation of HEK293 hTLR4 with H. vilamensis LOS 
elicited a poor NF-κB activation and CXCL-8 production, which were 
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significantly lower with respect to the values induced by E. coli LPS 
stimulation. 
 
Figure 52: Analysis of immunopotential of H. vilamensis LOS in HEK293 hTLR4 cell line. 
Activation of nuclear factor kappa B (A) and CXCL-8 production (B) in HEK 293 
hTLR4/MD2-CD14 stimulated with H. vilamensis LOS at the concentration of 1, 10, and 
100 mg/mL for 6 h. Commercial hexa-acylated Escherichia coli LPS or synthetic lipid IVA 
were used at the same concentrations as positive and negative control, respectively. Data 
are expressed as mean ± SD of three independent experiments in triplicate. *p < 0.05, **p 
< 0.01, and ***p < 0.001, after Student’s t-test. 
 
In order to confirm its low immunological impact, H. vilamensis LOS 
was also tested in human Monocytes-derived Macrophages (MoMs), which 
naturally expresses TLR4. Cells were exposed to H. vilamensis LOS at the 
concentration of 1, 10 and 100 ng/mL for 12 h. E. coli LPS was tested in 
parallel at same concentrations. Untreated cells and stimulation with Lipid 
IVa were used as negative control. The release of the pro-inflammatory 
cytokines TNF, interleukin-6 (IL-6) and interleukin-10 (IL-10) was assessed 
as readout. The results are shown in Figure 53. In agreement to what 
observed in the HEK293 hTLR4 cell model, with H. vilamensis LOS the 
release of these cytokines were significantly lower than those elicited by E. 
coli LPS at 10 and 100 ng/mL. However, the immunological activity was 
   
91 
 
significantly higher than E. coli LPS at 1 ng/mL and greater Lipid IVa at all 
concentration. This result demonstrate that H. vilamensis LOS possess a 
low immunostimulatory property. 
 
 
 
Figure 53: Analysis of immunopotential of H. vilamensis LOS in MOMs. Activation of tumor 
necrosis factor TNF (A), IL-6 (B) and IL-10 (C) release in cell-free supernatants of 
monocytes stimulated with H. vilamensis LOS at the concentration of  1, 10 and 100 
mg/mL for 12 h. Commercial hexa-acylated Escherichia coli LPS or synthetic lipid IVA 
were used at the same concentrations as positive and negative control, respectively. 
Abbreviation: NS: not stimulated. Data are expressed as mean ± SD of three independent 
experiments in triplicate. *p < 0.05, **p < 0.01, and ***p < 0.001, after Student’s t-test. 
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A complementary experiment with Bone marrow-derived 
macrophages (BMDMs) from C57BL/6 wild-type mice was performed in 
order to gain information about the signalling pathway activated by H. 
vilamensis LOS (Figure 54. A-B). BMDMs were exposed to H. vilamensis 
LOS at 1, 10, and 100 ng/mL. E. coli LPS and Lipid IVa were used 
respectively as positive and negative control, at the same concentrations as 
above. Untreated cells were also considered as the negative control. After 6 
h stimulation, TNF and Interferon inducible protein 10 (IP-10) production 
were quantified. As IP-10 is known to be induced by the TRIFF pathway103 
(See Section I), its release is indicative of a non-dependent MyD88 
signalling activation. The results obtained with the TNF release (Figure 54. 
A) are in accordance with the immunostimulatory activity observed with 
HEK293 hTLR4 and MoMs cell lines. However H. vilamensis LOS did not 
induce any significant release of IP-10, compared to the negative control 
Lipid IVa (Figure 54 B). This result suggest that H. vilamensis LOS slight 
agonist activity is not related to the TRIFF related signalling pathwatys and 
hence should be linked to an activation of the MyD88-dependent pathway. 
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A              B 
Figure 54: Analysis of immunopotential of H. vilamensis LOS in BMDMs. TNF (A) and IP-
10 (B) production stimulated with H. vilamensis LOS at the concentration of 1, 10, and 100 
mg/mL for 6 h. Commercial hexa-acylated Escherichia coli LPS or synthetic lipid IVA were 
used at the same concentrations as positive and negative control, respectively. 
Abbreviation: NS: not stimulated. Data are expressed as mean ± SD of three independent 
experiments in triplicate. *p < 0.05, **p < 0.01, and ***p < 0.001, after Student’s t-test. 
 
6.4. Investigation of Halopeptonella vilamensis core 
oligosaccharide region 
 
A mild acid hydrolysis was performed in order to separate the Lipid A 
from the oligosaccharide portion. The supernatant was then further purified 
by size exclusion chromatography. The sample was then analysed through 
NMR experiments. The proton spectrum revealed that the obtained product 
was a complex saccharide mixture containing up to 10 different units 
(Figure 55).  
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Figure 55: 1H NMR spectrum of H. vilamensis saccharidic product. Zoom of the anomeric 
region is reported in the inset 
  
 2D NMR spectra were analysed and showed that the 
oligosaccharide from H. vilamensis LOS could still not be resolved. Indeed, 
the present saccharide was in fact a mixture of several compounds. 
Moreover, no Kdo was detected during the analysis.  Further attempts to 
isolate the oligosaccharide are currently ongoing.  
  
6.5. Discussion 
 
The present study showed the characterisation of H. vilamensis LPS 
structure with the elucidation of its immunological activity. H. vilamensis is a 
strictly aerobic gamma-proteobacterium isolated from a hypersaline lake in 
Argentina. DOC-PAGE analysis of the extracted and purified content 
revealed that H. vilamensis possesses an LOS. Combining compositional 
analysis, MALDI-MS and MS/MS, it was possible to elucidate the structure 
of its Lipid A species. Careful analysis of the MALDI-MS revealed that H. 
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vilamensis actually possesses a highly heterogeneous mixture of bis-
phosphorylated Lipid As, differing in their acylation and the length of the 
acyl moieties H. vilamensis tri- to hexa-acylated Lipid As bearing C10:0 (3-
OH) as primary ester-linked fatty acids, C12:0 (3-OH) as amide-linked acyl 
chains and C10:1 (3-OH), C12:0, C12:1, C13:0, C14:0 and C14:1, as 
secondary ester-linked fatty acids. This remarkable heterogeneity was 
observed in the compositional analysis (Figure 45) and confirmed by 
MALDI MS on the intact Lipid A (Figure 46). It is herein represented on 
Figure 56. 
 
Figure 56: The complete structure of H. vilamensis Lipid A. Non stoichiometric substitution 
are denoted as dotted bonds 
 
It is the first time that H. vilamensis Lipid A is reported. The hexa-
acylated Lipid A species possess two structural feature that are shared 
among marine and halophiles104,105. Firstly, it has a 3+3 symmetry, contrary 
to the well-known Lipid A from E. coli that has a 4+2 symmetry. Secondly, it 
possess relatively short fatty acids chain. Indeed, E. coli fatty acids possess 
12 to 14 carbons atoms and H. vilamensis acyl chains are composed of 10 
to 12 carbon atoms.  
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The immunological assays demonstrated the slight agonist activity of 
H. vilamensis LOS. The symmetric repartition of the acyl chain and the 
occurrence of shorter fatty acids can explain why H. vilamensis LOS is less 
agonist than E. coli LPS. The biological assays also indicate that the 
activation of inflammatory response by H. vilamensis should follow the 
MyD88-dependent pathway. This work was performed in collaboration with 
Prof. Bernardini and complementary tests are being performed in order to 
fully understand H. vilamensis LOS immunological activity. 
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Section IV 
Looking for endotoxins among 
exopolysaccharides: the case of 
Halomonas smyrnensis 
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Chapter 7: Analysis of Halomonas 
smyrnensis polysaccharides 
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7.1. Sweet and salty:  an exopolysaccharide 
producing halophile  
 
Exopolysaccharides (EPS) are extra-polymeric substances secreted 
by various life forms, including bacteria. They are involved in many 
biological functions as aggregation, protection and symbiosis. Their 
diversity and particular properties made them appealing for several 
biotechnological applications as medicine and nutrition106. EPS from marine 
and extremophile micro-organisms have been extensively studied and 
bacteria from those ecological source possess a high variety of EPS 
structures107. In particular, halophiles (See Section III, 5.1) can produce 
particular EPS that can be used in industry as viscofier, gelling, emulsifying 
agents, therapy and bioremediation108.  
Among halophiles, bacteria belonging to the genus Halomonas are 
promising EPS producers. For example, Halomonas mauran produce a 
unique sulphated EPS that was called Mauran and studied for its 
biotechnological applications109. Discovered and isolated more recently 
Çamaltı Saltern Area in Turkey, Halomonas smyrnensis is a gamma-
proteobacterium that was also shown to be an EPS producer110. Further 
genomic analysis revealed that H. smyrnensis produce Levan111, a β-(2,6)-
linked fructose that was already known for its biotechnological 
applications112. Given its promising Levan-producing properties, H. 
smyrnensis is currently studied and used in order to make it viable for 
industrial use113.  
The present chapter reports the study of H. smyrnensis 
exopolysaccharide content. The usual procedure for LPS extraction and 
purification (See Section I, 2.1) was used and obtained products were 
analysed using NMR and 2D NMR experiments. 
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7.2. Extraction, purification and NMR spectroscopy  
 
H. smyrnensis cell wall components were extracted using hot 
Phenol-Water procedure and further purified by enzymatic treatment, 
extensive dialysis, centrifugation and size-exclusion column 
chromatography. Compositional analysis showed that the water phase was 
composed of a highly heterogeneous mixture of polysaccharides, while LPS 
related constituents, as Kdo and fatty acids, were almost absent. 
To further confirm that the LPS was present in a tiny amount, the 
water phase was treated by mild acid hydrolysis and its supernatant purified 
by size-exclusion column chromatography. Mass spectrometry of the pellet 
did not reveal the presence of the Lipid A. Chemical analysis was 
performed on the purified supernatant in order to determine the composition 
and branching points of its constituting polysaccharides. The GC-MS 
analysis of the partially methylated alditol acetates derivatives revealed that 
it was mainly composed of 4-glucose and 3-glucosamine. NMR 
experiments were then carried on the sample, in order to resolve the 
structure of this potential new exopolysaccharide. 
A combination 1D and 2D NMR experiments was performed. 1H 
NMR spectra confirmed that the extract was composed of a mixture of 
polysaccharides, herein termed as A (H1 at δ 5,07ppm) and B (H1 at δ 
4.99 ppm) (Figure 57).  
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Figure 57: Proton spectra of the EPS isolated from Halomonas smyrnensis 
 
COSY, TOCSY and HSQC experiments allowed the assignment of 
their respective spin systems (Table 5, Figure 58). A and B were both were 
considered as gluco-configured in the pyranose ring based on the large 
3JH,H ring coupling constant and their 1H and 13C chemical shift value. A was 
identified as an α-glucose. B was attributed to an α –N-Acetyl-glucosamine, 
as its C-2 chemical shift is indicative of a nitrogen-bearing carbon (C-2 at δ 
53.6 ppm) and gave its H-2 (δ 3,84 ppm) gave NOE contact with a methyl 
group (δ 1,99 ppm).  
 
 
Figure 58: 1H-13C HSQC NMR spectra of EPSs isolated from H. smyrnensis 
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Unit 1 2 3 4 5 6 
A 
α-Glc 5.07/98.6 3.70/68.4 3.82/69.1 3.85/77.5 3.94/69.4 3.86-3.91/64.5 
B 
α-GlcNAc 4.99/96.8 3.84/53.6 3.96/75.9 3.86/72.2 3.71/71.1 3.68-3.78/60.5 
 
Table 5: 1H and 13C (italic) NMR Chemical shift of EPSs isolated from H. smyrnensis. 
Additional chemical shifts: NAc at δ 1.99/22.3 ppm (CH3), 174,5 ppm (CO) 
 
Branching points between each monosaccharide unit were analysed 
by HMBC and NOESY spectra. It revealed that A and B were not each 
other connected and represented hence two separate homoglycans. 
Indeed, HMBC spectrum in anomeric region clearly showed signals that 
corresponded to ring closure and linkages within the same spins systems 
(Figure 59). Those linkages were consistent with previous GC-MS analysis. 
Moreover, the upfield shift of carbone resonance is indicative of 
glycosylation at those position (Table 5). A would hence be a homopolymer 
constituted of α-(1→4)-Glc and B constituted of α-(1→3)-GlcNAc (Figure 
60). 
 
Figure 59: 1H-13C HSQC (Blue) and 1H-13C HMBC (Red) NMR spectra of EPSs isolated 
from H. smyrnensis.    
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Figure 60: Structure of α-(1→4)-Glucose (A) and α-(1→3)-GlcNAc (B) 
 
7.3. Discussion 
 
Here, two homopolymers were identified as components of H. 
smyrnensis EPS content. The first one is an α-(1→4)-Glc polymer and the 
second polysaccharide is composed of α-(1→3)-GlcNAc. As previously 
described (See section 7.1.), the Halomonas genus is known to produce 
unique polysaccharides that have promising industrial application. Some 
new EPS are even named after the bacterium in which they were 
discovered, as Mauran from Halomonas maura. Mauran is an anionic, 
sulphated heteropolysaccharide with high uronic acid content that have 
pseudoplastic characteristic109. Finding new EPS is hence a promising way 
to discover new compounds for biotechnology. The occurrence in H. 
smyrnensis of the α-(1→4)-Glc polymer – known as amylose – is interesting 
as it is mostly produced by higher plants. Moreover, the α-(1→3)-GlcNac 
polymer is, at our knowledge, a novel polysaccharide. Further studies are 
needed in order to confirm their structure but those EPS can be specific to 
H. smyrnensis. Nevertheless, this chapter confirms that H. smyrnensis is a 
high EPS producer and synthetize EPS other than Levan.  
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Section V 
Experimental methods 
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Chapter 8: Material and Methods 
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8.1. Bacteria growth 
 
8.1.1. Pseudoalteromonas sp1A1 
Bacteria cells were provided by Garderes et al.67, who extracted 
Pseudoalteromonas sp1A1 on S. domuncula. Sponges were individually cut 
into small pieces (1 cm3) under sterile conditions. Pieces were washed 
three times with sterile seawater to remove epibiotic organisms. After 
incubation for 1 min of pieces from unhealthy specimens in 1 mL of sterile 
natural seawater, the suspension was spread onto Zobell agar medium 
(1.30 g L−1 yeast extract, 6.61 g L−1 peptone, 15.00 g L−1 agar in sea 
water, pH 7.4) to isolate opportunist bacteria. After 24 h of culture at 20 °C, 
the most occurring colony morphotype was picked and streaked onto fresh 
Zobell medium. 
 
8.1.2. Spiribacter salinus 
Bacteria cells were provided by Dr. Rodolfo Javier Menes92. The type 
strain S. salinus M19-40T (LMG 27464T) was obtained from Belgian 
Coordinated Collections of Microorganisms (BCCM (Gent, Belgium)). The 
bacterial strain was grown in modified growth medium (MGM18) broth at 30 
°C in an orbital shaker (200 rpm) and biomass was harvested after 15 days 
by centrifugation (10,000 x g). 
 
8.1.3. Halopeptonella vilamensis 
Bacteria cells were provided by Dr. Rodolfo Javier Menes101. Strain 
SV525T was isolated by serial dilutions in 0.9 % NaCl solution of sediment 
samples, spread-plated on MGM25 agar and incubated aerobically for 10 
days at 30 °C. MGM has the following composition (l−1): 5.0 g tryptone 
(Oxoid), 1.0 g yeast extract (Oxoid) and 600 ml or 833 ml (for MGM18 or 
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MGM25, respectively) of concentrated salt water (SW30) stock solution 
(Dyall-Smith 2009). The SW30 solution contained (l−1): 240 g NaCl, 30 g 
MgCl2·6H2O, 35 g MgSO4·7H2O, 7 g KCl and 5 ml 1 M CaCl2·2H2O. For 
solid medium 15 g of agar was added. The pH was adjusted to 7.5 ± 0.2, 
and the medium was autoclaved for 15 min at 121 °C. The strain was 
routinely grown on MGM18 agar at 30 °C for 5–7 days and maintained at 4 
°C for short-term preservation. 
 
8.1.4. Halomonas smyrnensis 
 Bacteria cells were provided by Kazan et al.110. Several pond soil 
samples from the Aegean Region of Turkey, with salt contents in the range 
30–50% and pH values of 6.5–7.5, were serially diluted with 0.9% (w/v) 
saline solution and spread on medium A containing (w/v) 0.5% yeast 
extract, 0.3% sodium citrate, 2% MgSO4 .7H2O, 0.2% KCl, 25% NaCl and 
1% agar. The pH of the medium was adjusted to 6.9 and plates were 
incubated at 37 °C. After one week of incubation a number of yellow–cream 
colonies had developed. They were purified using the repeated serial 
dilution technique followed by restreaking on solid enrichment medium A 
and the purity of the isolates was examined based on cell shape under a 
microscope and colony homogeneity on the plates. Four isolates, 
designated AAD6T, AAD4, AAD17 and AAD21 and belonging to the same 
genus based on 16S rRNA gene sequence analysis, were studied for 
phenotypic characteristics. Subculturing was performed on samemediumfor 
24 h at 37 °and bacterial isolates were maintained as glycerol stocks at -70 
°C for further studies. 
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8.2. Extraction of LOS and LPS  
 
 Dried cells were washed three times with water, ethanol and acetone 
and then lyophilized. The PCP extraction was then performed on the 
washed cells. A solution of Phenol/Chloroform/Light Petroleum (2:5:8 v/v/v) 
was prepared. The cells were then dissolved at a concentration of 10 mL/g 
of cells. The solution was stirred for 1 h at room temperature and then 
centrifuged for 20 min at 8000 rpm. The supernatant was collected in a 
round bottom flask and the extraction was repeated twice. The solution was 
concentrated under vacuum until phenol is the only solvent left in the flask. 
The solution was then transferred in a falcon, few drops of water were 
added and a centrifugation was performed for 40 min at 8000 rpm.  
The Hot Phenol-Water procedure was hence performed on the 
remaining cells. A solution of Phenol/Water (1:1) was prepared and the 
cells were dissolved at a concentration of 40 mL/g of cells. The solution 
was stirred for 1h at 70 °C. It was then centrifuged for 30 min at 4 °C and 
8000 rpm. The water phase was transferred in a Falcon and the extraction 
was repeated twice. At the end, the Phenol phase was diluted three times 
in water. Both water and phenol phases were then separately dialysed 
against distilled water (cut-off 12–14 kDa) and lyophilised. 
 The water phase underwent an enzymatic treatment. It was first 
digested by RNase and DNase for 5h at 37°C. Protease were then added 
and the reaction was let overnight at 56°C. The digested material was 
extensively dialysed against distilled water (cut-off 12–14 kD) and 
lyophilised. The partially purified product was analysed by DOC-PAGE, 
which was followed by gel staining with silver nitrate, using the described 
procedure49.  
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8.3. Chemical analysis 
  
8.3.1. MGA analysis 
An aliquot of LPS/LOS was dried under vacuum for 1 h. It was then 
dissolved in 300 µL of MeOH/HCl and the reaction was performed overnight 
at 85 °C. The solvent was then removed under an air flow and the solution 
neutralised with several washes using MeOH. The product was dried again 
under vacuum for 30 min. 25 µL of acetic anhydride (Ac2O) and 25 µL of 
pyridine were then added and the reaction was performed at 85 °C for 30 
min. The solvent was is removed under air flow. The product in then diluted 
in CHCl3 and three washes with water were performed. The CHCl3 phase 
was dried under air flow. The sample was then diluted in 100 µL of acetone 
and injected in GC-MS. 
 
8.3.2. AAPM analysis 
An aliquot of LPS/LOS was dried under vacuum for 1h. It was then 
dissolved in 500 µL DMSO with NaOH and the solution was stirred for 1h 
30 at room temperature. 300 µL of CH3I was added and the reaction was 
done overnight at room temperature. The solvent was then removed for 1 h 
under an air flow. The sample was dissolved in CHCl3 and several washes 
with water were performed. The CHCl3 was removed under air flow and the 
sample was dried for 30 min under vacuum. 300 µL of TFA 2M were added 
and the reaction was done for 2 h at 120 °C. The TFA was removed under 
air flow and the sample was neutralized with several washes of MeOH. The 
sample was then diluted in 300 µL of EtOH and one spatula tip of NaBD4 
was added. The solution was stirred overnight at room temperature and the 
reaction was stopped with few drops of HCl. The solvent was removed 
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under air flow and once again neutralized with several washes with MeOH. 
The sample was dried 30 min under vacuum and 25 µL of acetic anhydride 
(Ac2O) and 25 µL of pyridine were added. The reaction was performed at 
85 °C for 30 min. The solvent is removed under air flow. The product was 
then diluted in CHCl3 and washed three times with water. The CHCl3 phase 
was dried under air flow and the sample is then diluted in 100 µL of 
acetone. It was then injected in GC-MS. 
 
8.3.3. Analysis of Fatty acids Methyl-ester derivatives 
An aliquot of LPS/LOS is dried under vacuum for 1 h. The 
methanolysis is then performed with HCl.MeOH, as described for MGA 
procedure (8.3.1). The product is then extracted with three time 500 µL of 
hexane. A fraction of the hexane layer was then injected in GC-MS. 
 
8.4. Isolation of Lipid A and Polysaccharides 
moieties 
 
 8.4.1. Isolation of Pseudoalteromonas sp1A1 O-antigen  
 An aliquot of the extracted LPS (20 mg) was dried under vacuum for 
2 h. Hydrazine (1,3 mL) was added and the sample was stirred at 37 °C for 
2 h. Cold acetone was added and the solution was centrifuged at 4 °C, 
4000 rpm for 15 min. The supernatant was removed and the pellet was 
washed two other times with acetone. The pellet was dried under air flow 
and lyophilized. The product was then dissolved in a solution of KOH 4 M 
(1,3 mL) and the reaction was done overnight at 120 °C. The solution was 
neutralized with HCl 4 M and extracted three times with HCl. The water 
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phase was isolated and lyophilized. The salt-containing product was 
purified using gel filtration chromatography Sephadex G- 10 (GE 
Healthcare). The de-salted product was further purified by size-exclusion 
chromatography Bio-Gel P-10 (Bio-Rad). The purified polysaccharide was 
dissolved in 500 µL D2O and analysed by NMR spectroscopy. 
 
 8.4.2. Isolation of Pseudoalteromonas sp1A1 Lipid A 
In order to isolate the lipid A component, an aliquot of pure LPS (20 
mg) was treated with acetate buffer (pH 4.4, 5 h, 100 °C) under magnetic 
stirring. An appropriate mixture of methanol and chloroform was added to 
the hydrolysate to obtain a methanol/ chloroform/hydrolysate 2:2:1.8 (v/v/v) 
ratio. The mixture was then shaken and centrifuged. The chloroform phase, 
containing the lipid A, was collected and washed with the water phase of a 
freshly prepared Bligh/Dyer mixture (chloroform/methanol/water, 2:2:1.8)114. 
This wash step was executed several times and all the organic phases 
were then collected and dried.  
 
 8.4.3. Isolation of Spiribacter salinus M19-40T Lipid A  
The extracted LOS was further purified by ultracentrifugation (4 °C, 
45,000 rpm, 48 h) and then by size-exclusion chromatography on a 
Sephacryl High Resolution S-200 (GE Healthcare) column. An aliquot of the 
pellet (10 mg) was then treated by mild acidic hydrolysis as described in 
paragraph 8.4.2. Another aliquot of lipid A was also treated with 10% 
ammonium hydroxide, as previously reported56. The sample was dried and 
analyzed by MALDI MS. 
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8.4.4. Isolation of Halopeptonella vilamensis 
polysaccharides  
The extracted material was further purified by by size-exclusion 
chromatography on a Sephacryl High Resolution S-500 (GE Healthcare) 
column. An aliquot of the product (30 mg) was treated by mild acidic 
hydrolysis with an acetate buffer (pH 4.4, 2 h, 100 °C). The solution was 
then centrifuged (4 °C, 7000 rpm, 1 h) and the pellet was washed twice with 
water. The supernantant were collected and lyophilised. The product was 
then purified by size-exclusion chromatography on a Sephacryl High 
Resolution S-100 (GE Healthcare) column. The purified extract was 
lyophilized, dissolved in 500 µL D2O and analysed by NMR spectroscopy. 
 
 8.4.5. Isolation of Halopeptonella vilamensis Lipid A  
The extracted LOS was further purified by size-exclusion 
chromatography on a Sephacryl High Resolution S-300 (GE Healthcare) 
column. An aliquot of the sample (25 mg) was then treated by mild acidic 
hydrolysis and underwent an ammonium treatment as previously described 
(See paragraph 8.4.2). Treated Lipid As were dried and analysed by MALDI 
MS.  
 
 8.4.6. Isolation of Halomonas smyrnensis 
polysaccharides  
An aliquot of the extracted LPS (15 mg) was dried under vacuum 
and underwent a full de-acylation procedure, as described in paragraph 
8.4.1. The salt-containing product was purified using gel filtration 
chromatography Sephadex G10 (GE Healthcare). The de-salted product 
was further purified by size-exclusion chromatography Bio-Gel P-2 (Bio-
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Rad). The purified polysaccharide was dissolved in 500 µL D2O and 
analysed by NMR spectroscopy. 
 
8.5. Mass Spectrometry  
 
A reflectron MALDI-TOF MS and MS2 analysis was performed on an 
ABSCIEX TOF/TOFTM 5800 Applied Biosystems mass spectrometer, 
equipped with an Nd:YLF laser with a λ of 345 nm, a <500 ps pulse length, 
and a repetition rate of up to 1000 Hz. The lipid A fraction was dissolved in 
chloroform/methanol (1:1, v/v), as previously described115. The matrix was 
the trihydroxyacetophenone (THAP) dissolved in 
methanol/0.1%trifluoracetic acid/acetonitrile (7:2:1, v/v/v) at a concentration 
of 75 mg.mL-1. The ammonium-treated lipid A was dissolved in chloroform-
trifluoroethanol (4:1, v/v) and the matrix used was 2,5-dihydroxy benzoic 
acid in acetonitrile 0.2% trifluoroacetic acid (7:3, v/v)56. Lipid A preparation 
of 0.5 µL and 0.5 µL of the matrix solution were deposited on the MALDI 
plate and left to dry at room temperature. Each spectrum was a result of the 
accumulation of 1500 laser shots, whereas 6000–7000 shots were summed 
for the MS2 data acquisitions116. The reported MS2 spectra were all 
acquired without collision gas. Nevertheless, MS2 experiments were 
executed with argon or air as the collision gas, and the resulting 
fragmentation spectra were compared with those that were obtained 
without collision-induced dissociation. No large differences were observed 
in all of the cases in the mass range above m/z 200. Below this mass, the 
product ions corresponding to the phosphate fragments at m/z 79 and 97 
were far more abundant in the collision-induced dissociation spectra, 
regardless of the collision gas. 
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8.6. NMR spectroscopy 
  
 1D and 2D NMR spectra were performed at 298 K in D2O at pD = 7 
with a cryoprobe-equipped Bruker 600DRX spectrometer. The spectra were 
calibrated with internal acetone (H = 2.225 ppm; C = 31.45 ppm). Total 
correlation spectroscopy (TOCSY) experiments were performed with 
spinlock times of 100 ms by using data sets (t1 x t2) of 4096 x 512 points. 
Rotating frame Overhauser enhancement spectroscopy (ROESY) and 
Nuclear Overhauser enhancement spectroscopy (NOESY) experiments 
were executed by using data sets (t1 x t2) of 4096 x 512 points with mixing 
times between 100 and 300 ms. Double-quantum-filtered phase sensitive 
correlation spectroscopy (DQF-COSY) experiments were executed by 
using data sets of 4096 x 900 points. The data matrix in all the 
homonuclear experiments was zero-filled in both dimensions to give a 
matrix of 4K x 2K points and was resolution-enhanced in both dimensions 
by a cosine-bell function before Fourier transformation. Coupling constants 
were determined by 2D phase-sensitive DQF-COSY117, 118. Heteronuclear 
single quantum coherence (HSQC) and heteronuclear multiple bond 
correlation (HMBC) experiments were executed in 1H-detection mode by 
single-quantum coherence with proton decoupling in the 13C domain using 
data sets of 2048 x 400 points. HSQC was performed using sensitivity 
improvement and in the phase-sensitive mode using Echo/Antiecho 
gradient selection, with multiplicity editing during the selection step119. 
HMBC was optimized on long range coupling constants, with a low-pass J-
filter to suppress one-bond correlations, using gradient pulses for selection, 
and a 60 ms delay was used for the evolution of long-range correlations. 
The data matrix in all the heteronuclear experiments was extended to 2048 
x 1024 points by using forward linear prediction extrapolation120. 
  
   
115 
 
8.7. Biological assays  
 
8.7.1. ELISA and Quanti-Blue assays with LPS from 
Pseudoalteromonas sp1A1  
Those experiments were performed in collaboration with Prof. 
Bayeart. THP-1 cells were seeded in a 96-well plate at 105 cells well-1 in 
complete medium (140 µL) and were stimulated overnight at 37°C with TPA 
(12-O-Tetradecanoylphorbol-13-acetate). The next day, cells that did not 
adhere were removed using complete culture medium, and the plated were 
left for 1h to recover with complete medium (180 µL). Cells were either 
stimulated with Pseudoalteromonas sp1A1 LPS or E. coli LPS (InvivoGen) 
at the indicated concentrations. The Pseudoalteromonas sp1A1 LPS and E. 
coli LPS were added as solutions in complete medium (20 µL) to reach a 
200 mL total volume of the well after stimulation. The cells were incubated 
overnight at 37°C with 5% CO2. The supernatants were analysed for TNF 
production by ELISA (BD Biosciences). Data are representative of three 
independent experiments. Errors bars indicate standard error of the mean 
of triplicate samples. 
Raw-blue-hTLR4 cells were detached with Tripsin then seeded in a 
96-well plate at 5.104 cells well-1 in complete medium (180µL) and 
incubated overnight. Cells were simultaneously stimulated with 
Pseudoalteromonas sp1A1 LPS and E. coli LPS at the indicated 
concentrations. The Pseudoalteromonas sp1A1 LPS and E. coli LPS were 
added as solutions in complete medium (20 µL) to reach a 200 mL total 
volume of the well after stimulation. The cells were incubated overnight at 
37°C and 5% CO2, and the supernatants were analysed for Secreted 
Alkaline Phosphate (SEAP) production by Quanti-blue Assay. Data are 
   
116 
 
representative of three independent experiments. Error bars indicate 
standard error of the mean of triplicate samples. 
 
8.7.2. Cell culture and ELISA with H. vilamensis LOS 
 Those experiments were performed in collaboration with Prof. 
Bernardini. HEK293 cell line, stably transfected with human TLR4/MD2-
CD14 (InvivoGen) was seeded into 96-well plate at the concentration of 1 × 
105 cells/mL. 48 h after seeding the cells were transiently transfected 
through PolyFect Transfection Reagent (Qiagen) with a reaction mix 
containing 150 ng of Firefly luciferase reporter constructs, pGL3.ELAM.tk 
[harboring nuclear factor kappa B (NF-κB) promoter sequences], and 15 ng 
of Renilla luciferase reporter plasmid, pRLTK (as an internal control). The 
day after the cells were incubated with different concentrations of H. 
vilamensis LOS (1, 10, and 100 ng/mL), or with purified E. coli LPS (LPS-
EB ultrapure; InvivoGen) or with synthetic lipid IVA used at the same 
concentrations as above, for 6 h to analyze NF-κB activity (Dual Luciferase 
Reporter Assay System, Promega) and to measure CXCL-8 release 
(DuoSet R&D System).  
Peripheral blood mononuclear cells were isolated from buffy coats 
obtained by the blood bank of Sapienza University from healthy adult 
volunteers (blood donors) following written informed consent. CD14+ 
monocytes were isolated from PBMCs using the MACS system (Miltenyi 
Biotec, Bergisch Gladbach, Germany) and cultured in complete RPMI 1640 
medium (Lonza, Italy, Milan), supplemented with 10% of heat-inactivated 
FBS (HycloneTM, Euroclone, Italy, Milan), 1% di l-glutammine (Lonza), 1% 
of non-essential amino acid solution (NEEA—Lonza), 1% sodium pyruvate 
(Lonza), penicillin 100 U/mL–streptomycin 100 μg/mL (Lonza), and 0.1% di 
2-ME (Gibco, Italy). CD14+ monocytes were seeded at the concentration of 
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5 × 105 cells/well in 12-multiwell plate and exposed to 1, 10 and 100 ng/mL 
of LOS from H. vilamensis or to commercial E. coli O111:B4 LPS or to 
synthetic lipid IVA at same concentrations as above for 12 h. Cell 
supernatants were then collected and processed for ELISA to the levels of 
TNF and IL-6. 
Murine and human cytokines were determined in supernatants of 
stimulated cells by using R&D Systems DuoSet ELISA kits according to the 
manufacturers’ instructions. Student's paired t test was used to determine 
the statistical significance of the data. 
 
8.8. Molecular Dynamic Simulation  
 
A 128 lipid bilayer was generated using CHARMM-GUI Membrane 
Builder (http://www.charmm-gui.org/). Each leaflet was composed of a 3:1 
ratio of palmitoyloleoyl phosphatidylethanolamine (POPE) and 
palmitoyloleoyl phosphatidylglycerol (POPG). Pseudoalteromonas sp1A1 
Lipid A and LOS were built using PyMOL software (http://www.pymol.org) 
and GLYCAM database (http://www.glycam.org). The atomic partial 
charges of the residues were calculated with Gaussian and formatted for 
AMBER14 with antechamber. Atoms and charges were assigned according 
to AMBER ff11, ff14 and Glycam force fields. Free Lipid A and LOS were 
immersed in an octaedric box of explicit TIP3P water molecules.  
MD simulations were run with AMBER14. All hydrated systems were 
firstly equilibrated with 1000 steps of steepest descent minimization 
followed by 7000 steps of conjugate gradient algorithm. They were then 
heated from 0 to 100 K, with the Langevin thermostat and applying 10 
kcal·mol−1.A−2 restrain. The systems were then heated until 300 K with no 
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restrain. After equilibration, 100ns MD simulation was performed at 
constant temperature (300°C) and pressure (1 atm) at a 2 fs time step. At 
the end of the simulation, hydrophobic thickness and area per lipid were 
calculated with the help of the ptraj module of AmberTools 14. 
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Conclusion 
 
 The investigation of new LPS/LOS structure, and in particular of their 
Lipid A, is necessary in order to develop new therapies. In this context, the 
LPS from Pseudoalteromonas sp1A1 and the Lipid A from Spiribacter 
salinus M19-40T and Halopeptonella vilamensis were characterized. 
Pseudoalteromonas sp1A1 O-antigen possesses an hexa-
saccharidic repeating unit with the notable presence of a pyruvate 
substituent and the KDN. Pseudoalteromonas sp1A1 also possesses a 
mixture of two mono-phosphorylated and penta-acylated Lipid A. Its main 
species is composed of four C12:0 (3-OH) and one C12:0. The secondary 
species is bearing one C10:0 (3-OH), two C12:0 (3-OH), one C11:0 (3-OH) 
and one C13:0. The core region from Pseudoalteromonas sp1A1 is a 
pentasaccharide containing one Kdo, one heptose, two galactose and one 
glucose. Concerning its biological properties, Pseudoalteromonas sp1A1 
does not possess significant agonist or antagonist activity. Finally, MDS 
highlighted that the Outer-membrane of Pseudoalteromonas sp1A1 
possesses a high flexibility due to the asymmetric repartition of its Lipid A. 
MDS of the LOS in water and with 0.5M of NaCl showed that the presence 
of salt could influence the conformational angle between the Kdo of the 
core oligosaccharide and its linked glucosamine. Such properties could be 
due to the presence of several negatively-charged phosphate groups that 
can interact with the surrounding Na+. It is worth noticing such difference. 
Indeed, a change of the LOS conformation can lead to different biological 
properties in water and in marine environments. 
 The Lipid A structure from Spiribacter salinus M19-40T was 
elucidated. It is mono-phosphorylated and penta-acylated and contains two 
C10:0 (3-OH), one C12:0, one C14:0 (3-OH) and one C14:0 (3-oxo). It has 
   
120 
 
an unusual 2+3 symmetry that is shared with some marine bacteria. The 
precence of the C14:0 (3-oxo) is also remarkable and had previously been 
found in Rhodobacter capsulatus Lipid A. It is a promising result as this 
Lipid A inspired the synthetic analogue Eritoran that reached phase III of 
clinical trials as an anti-sepsis agent. This finding is encouraging for the 
research of new LPS structure from halophiles. Halopeptonella vilamensis 
lipid A was also characterised, and turned out to be composed of a highly 
heterogeneous mixture a bis-phosphorylated species. It is characterized by 
a mixture of tri-, tetra-, penta- and hexa-acylated species. Primary fatty 
acids C12:0 (3-OH) and C10:0 (3-OH) were respectively found as 
acyloxyamide and acyloaxyl ester directly linked to the di-glucosamine 
backbone. The Lipid A was also substituted by a mixture of C12:0, C12:1, 
C14:0 and C14:1 as secondary acyl chains. Immunological assays showed 
that H. vilamensis LOS has a slight agonist activity. Finally, H. smyrnensis 
EPS content was analysed using NMR spectroscopy, two novel 
homopolymers were found. The first one is formed by α-(1→4)-Glc polymer 
and the second one by α-(1→3)-GlcNAc units. As for the α-(1→4)-Glc 
polysaccharide is intriguing to find it produced by a halophilic bacterium. 
Moreover, the α-(1→3)-GlcNAc polymer is at our knowledge a novel 
polysaccharide that differ from homologues structure from its linkages. 
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 ANNEX  
 
Papers related to this PhD project 
  
- Barrau, C.; Di Lorenzo, F.; Javier Menes R.; Lanzetta R.; Molinaro 
A.; Silipo A.; Mar. Drugs 2018, 16, 124 
 
- Barrau, C. et. al. Structure and activity of the LPS of 
Pseudoalteromonas sp1A1, manuscript in preparation  
  
- Barrau, C. et. al. Structure and activity of the Lipid A from the 
halophilic bacterium Halopeptonella vilamensis, manuscript in 
preparation  
 
Attended congress, conferences, meeting, and 
workshop 
 
- 2nd TOLLerant meeting, 24-27/05/2016, Madrid, Spain. 
- XV CSCC, 19-22/06/2016, Certosa di Pontignano, Italy 
 Poster communication: Structure of potential agonist and 
antagonist LPS from extremophile bacteria – Clara Barrau; 
Flaviana Di Lorenzo; Antonio Molinaro; Alba Silipo 
- Structural Glycoscience Workshop, 28-30/06/2016, Grenoble, 
France 
- 3rd TOLLerant meeting, 14-16/12/2016, Ljubljana, Slovenia 
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- 4th TOLLerant meeting, 5-7/06/2017, Naples, Italy 
- EUROCARB, 2-6/07/2017, Barcelona, Spain 
 Poster communication: Structure of potential agonist and 
antagonist LPS from extremophile bacteria – Clara Barrau; 
Flaviana Di Lorenzo; Antonio Molinaro; Alba Silipo 
- NAPOSAKA meeting, 10/07/2017, Naples, Italy 
 Oral communication: Structure of potential agonist and 
antagonist LPS from extremophile bacteria – Clara Barrau; 
Flaviana Di Lorenzo; Antonio Molinaro; Alba Silipo 
- 5th TOLLerant meeting, 12-15/12/2017,Ghent, Belgium 
- XVI CSCC, 17-20/06/2018, Certosa di Pontignano, Italy 
 Poster communication: Structure of Lipooligosaccharides from 
halophilic bacteria - Clara Barrau; Flaviana Di Lorenzo; 
Antonio Molinaro; Alba Silipo 
- 2nd NAPOSAKA meeting, 25/06/2018, Naples, Italy 
 Oral communication: Structure of Lipooligosaccharides from 
halophilic bacteria - Clara Barrau; Flaviana Di Lorenzo; 
Antonio Molinaro; Alba Silipo 
- 29th International Carbohydrate Symposium (ICS 2018), 15-
19/07/2018, Lisbon, Portugal 
 Poster communication: Structure of Lipooligosaccharides from 
halophilic bacteria - Clara Barrau; Flaviana Di Lorenzo; 
Antonio Molinaro; Alba Silipo 
- IASOC, 22-25/09/2018, Naples, Italy 
 Poster communication: Structure of potential agonist and 
antagonist LPS/LOS from marine and halophilic bacteria - 
Clara Barrau; Flaviana Di Lorenzo; Antonio Molinaro; Alba 
Silipo 
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Attended internal seminars 
Title Speaker Date 
Solid State NMR Dr. Guido Pintacuda 22 to 24/02/2016 
Basics of detergents 
formulations and 
challenges 
Dr. Giulia Bianchetti 16/03/2016 
Progettazione risk 
assessment e controllo 
qualità del packaging 
alimentare : il ruolo 
intteso del consulente 
chimico 
Dr. Vicenzo Benessere 17/03/2016 
Metalloproteins, 
mimics by design Dr. Angela Lombardi 12/10/2016 
Chemical Biology and 
medicinal chemistry of 
glycoscphingolipid 
metabolism 
Prof. Herman 
Overkleeft 19/12/2016 
Discovery of novel 
hyperthermophilic 
carbohydrate active 
enzyme for biomass 
degradation 
Prof. Andrea Strazzulli 8/03/2017 
Non-entropic 
contribution to 
reinforcement in filled 
elastomers 
Dr. Paul Sotta 08/06/2017 
Structural 
Bioinformatics: a 
window to observe 
new asects of protein 
behavious 
Prof. Neri Niccolai 8/06/2017 
Chemical synthesis of 
homogeneous 
glycoproteins 
Prof. Yasuhiro 
Kajihara 14/11/2017 
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Attended courses 
 
Title Professor 
Glycoscience Prof. Michelangelo Parrilli  Dr. Emiliano Bedini 
Advanced Mass 
spectrometry Prof. Pietro Pucci 
NMR of Biomolecules Prof. Delia Picone 
Spettroscopia Intrepretativa 
NMR Organica Prof. Antonio Evidente 
Recombinant production of 
natural and mutant proteins Prof. Angela Dulio 
Ecotoxicology: principles 
and main applications Prof. Giovanni Pagano 
 
Short stay in European Laboratories 
 
- VIB, Ghent, Belgium (November 2016). Secondment made within 
Prof. Bayeart’s team. Immunological assays of purified LPS. Results 
are presented in Section II, 3.6. 
 
- CIB-CSIC, Madrid, Spain (April-May 2017). Secondment made 
within Prof. Martín-Santamaria’s team. Molecular Dynamic 
simulation of LOS and Outer-membrane. Results are presented in 
Section II, 4. 
Chemical synthesis 
and characterization of 
chondroitin sulfate 
Prof. Jun-Ichi Tamura 23/07/2018 
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- DIOMUNE, Madrid, Spain (September 2017). Secondment made 
within Dr. Llamas’s team. Training about sepsis model in vivo. 
Experience in industry and learning about the elaboration of a 
business plan. 
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